Latest

Eurozone Services Growth Slows in October as France Contracts Sharply Eurozone services activity continued to expand in October, but momentum

Eurozone services activity continued to expand in October, but momentum weakened more than expected as a sharp contraction in France offset relatively resilient readings...

11-04-26

China Services PMI Falls to 50.8 in October, Missing Forecasts China’s RatingDog Services PMI fell to 50.8 in October, below

China’s RatingDog Services PMI fell to 50.8 in October, below the 51.7 forecast and down from 51.6 in the previous month. The reading remained...

11-04-26

Halliburton Launches AI-Powered Agile Asset Management for Oil and Gas Investment Decisions Halliburton (NYSE: HAL) introduced Agile Asset Management, a

Halliburton (NYSE: HAL) introduced Agile Asset Management, a new AI-powered, cloud-based Landmark solution designed to help oil and gas companies evaluate field-development alternatives and...

11-03-26

Broadridge Reaffirms FY27 Outlook as Recurring Revenue Grows 11% Broadridge Financial Solutions (NYSE: BR) reported a solid start to fiscal

Broadridge Financial Solutions (NYSE: BR) reported a solid start to fiscal 2027, with double-digit recurring revenue growth and stronger closed sales, while profitability was...

11-03-26

L3Harris Receives $36 Million U.S. Army SATCOM Order for C2NOW Program L3Harris Technologies (NYSE: LHX) received a $36 million order

L3Harris Technologies (NYSE: LHX) received a $36 million order from the U.S. Army for its Hawkeye 4 Lite satellite communications terminals, supporting the military’s...

11-03-26

CrowdStrike Expands AI Security Integrations With AWS CrowdStrike (NASDAQ: CRWD) announced new integrations with Amazon Web Services designed to extend

CrowdStrike (NASDAQ: CRWD) announced new integrations with Amazon Web Services designed to extend Falcon protection across AI applications, agentic workflows and cloud infrastructure. The...

11-03-26

Tradeweb Launches Muni Sweep to Speed Municipal Bond Trading Tradeweb Markets (NASDAQ: TW) launched Muni Sweep, a new session-based trading

Tradeweb Markets (NASDAQ: TW) launched Muni Sweep, a new session-based trading protocol designed to help municipal bond market participants evaluate and trade inventory more...

11-03-26

Accenture and Kbrw Help Orange France Modernize Order Fulfillment Across Sales Channels Accenture (NYSE: ACN) and French supply chain software

Accenture (NYSE: ACN) and French supply chain software company Kbrw have been selected by Orange France to modernize the telecom operator’s order management and...

11-03-26

Snowflake Expands Agentic AI Push With CoCo and CoWork Bots Snowflake (NYSE: SNOW) unveiled a major expansion of its enterprise

Snowflake (NYSE: SNOW) unveiled a major expansion of its enterprise AI platform at Snowflake Expedition 2026, introducing new autonomous capabilities for CoCo and CoWork...

11-03-26

U.S. Job Openings and Factory Orders Beat Forecasts in September U.S. economic data came in stronger than expected in September,

U.S. economic data came in stronger than expected in September, with both job openings and factory orders exceeding market forecasts. JOLTS job openings rose...

11-03-26

Zebra Technologies Plunges 12% as Margin Compression Overshadows Strong Growth and Raised Outlook Zebra Technologies (NASDAQ: ZBRA) shares fell about

Zebra Technologies (NASDAQ: ZBRA) shares fell about 12% despite reporting strong third-quarter 2026 revenue growth, higher earnings and an increased full-year outlook. Third-quarter sales...

11-03-26

Dynatrace Plunges 15% as Strong Q2 Growth Fails to Offset Concerns Over Forward Expectations Dynatrace (NYSE: DT) shares fell about

Dynatrace (NYSE: DT) shares fell about 15% despite reporting solid second-quarter fiscal 2027 growth, strong margins and an expanded share repurchase authorization. Annual recurring...

11-03-26

NASDAQ:AAPLFollow

Track all markets on TradingView - Prices are not updated in real time

Apple Falls 4.5% Premarket Despite Record Q4 Revenue as Tariff Refunds Boost Reported Margins

Apple (NASDAQ: AAPL) shares fell about 4.5% in premarket trading despite reporting record fiscal fourth-quarter 2026 revenue, iPhone sales and earnings per share.

Quarterly revenue rose 12% year over year to $114.5 billion, marking a September-quarter record. Apple also said iPhone revenue reached a September-quarter high, while Services revenue set a new all-time record.

Diluted EPS increased 14% to $2.10. Gross margin was 47.9%, but the quarter benefited from approximately 1 percentage point of favorable impact from tariff refunds. The refunds also added about $0.05 to EPS, meaning part of the reported margin and earnings strength came from a non-recurring benefit.

Apple generated $28 billion of operating cash flow during the quarter and returned $28 billion to shareholders. For the full fiscal year, revenue reached a record $479 billion, while the installed base of active devices also reached new highs across major product categories and geographic regions.

The company highlighted its new iPhone lineup, expanded home hardware portfolio and the rollout of its new Siri AI capabilities as key products heading into the holiday season.

The 4.5% premarket decline suggests investors are looking beyond the strong headline numbers. One possible concern is the quality of the margin and EPS beat, given the meaningful contribution from tariff refunds. With the press release not providing detailed forward guidance, the selloff may also reflect expectations that were already elevated ahead of the report, leaving the market focused on underlying profitability and the sustainability of growth once temporary tariff benefits are excluded.

💬 🔗

Global Finance News 11-03-26

Apple unveils groundbreaking MacBook Pro with PROLED XDR Display - Apple

Apple today introduced the all-new MacBook Pro with PROLED XDR Display featuring breakthrough tandem OLED technology.

(apple.com)

💬 🔗

Global Finance News 11-01-26

Apple Launches New Mac mini and Mac Studio With M6 and M5 Ultra Chips

Apple said its latest Mac mini and Mac Studio models are now available, expanding the company’s desktop lineup with new Apple silicon aimed at stronger AI, graphics and professional computing performance.

The new Mac mini is offered with the M6 or M5 Pro chip. Apple said the M6 version delivers up to 4x faster AI performance, 2x faster graphics and storage performance, and 40% faster CPU performance compared with the prior-generation model. The M5 Pro configuration is aimed at more demanding workloads such as video production and game development.

Mac Studio now comes with M5 Max or M5 Ultra. The M5 Ultra version supports up to a 36-core CPU, an 80-core GPU and 512GB of unified memory, while Thunderbolt 5 with RDMA support allows multiple Mac Studio systems to be clustered for distributed AI inference.

Both systems are positioned heavily around on-device AI and run macOS 27, which includes Siri AI and other Apple Intelligence features. Apple is increasingly emphasizing local AI workloads, agentic workflows and large-model inference as part of its Mac strategy.

Pricing starts at $899 for Mac mini with M6 and $2,499 for Mac Studio with M5 Max. The M5 Ultra version starts at $5,499.

💬 🔗

Global Finance News 09-22-26

The latest iPhone, Apple Watch, and AirPods lineups arrive in stores worldwide - Apple

On Friday, September 18, Apple Store locations around the world introduced customers to the iPhone 18 Pro lineup, Apple Watch Series 12, Apple Watch Ultra 4, and AirPods 5.

(apple.com)

💬 🔗

Global Finance News 09-19-26

Apple Rolls Out Siri AI Across Its Software Platforms

Apple (NASDAQ: AAPL) has begun rolling out major software updates across its ecosystem, headlined by Siri AI and the next generation of Apple Intelligence.

Siri AI is designed as a more conversational and context-aware assistant, with the ability to understand information across messages, emails and photos, recognize what is displayed on a user’s screen and perform more actions across apps. The beta is initially rolling out in English, with additional languages planned for October.

Apple is also expanding generative AI throughout its products. New capabilities include Write with Siri, AI-powered photo editing and image generation, smarter Safari tab organization and website-change alerts.

The updates are rolling out across iOS 27, iPadOS 27, macOS 27, watchOS 27, visionOS 27 and tvOS 27. However, Siri AI will initially face regional limitations, including no availability in China while Apple works through regulatory requirements.

The launch represents a major step in Apple’s effort to integrate generative AI more deeply across its hardware and software ecosystem and strengthen its position in the rapidly expanding consumer AI market.

💬 🔗

The Investor 09-15-26

Broadcom and Apple, and the End of Apple’s Run of Squeezing Suppliers? | Chip Stock Investor

💬 🔗

The Investor 09-15-26

Top Stock Market Highlights of the Week: Apple, Qualcomm, Sembcorp Industries and Mapletree Logistics Trust

We look at Apple's shift to a split iPhone launch strategy, a major AI chip partnership, and two corporate developments from Singapore-listed companies.

(thesmartinvestor.com.sg)

💬 🔗

The Investor 09-12-26

Apple unveils iPhone Duo - Apple

Apple today introduced iPhone Duo, the first foldable iPhone.

(apple.com)

💬 🔗

The Investor 09-10-26

Apple Stock in Focus as Rothschild & Co Redburn Upgrades AAPL to Buy, Sets $400 Target

Apple (NASDAQ: AAPL) shares are in focus Monday after Rothschild & Co Redburn upgraded the iPhone maker to Buy from Neutral and set a $400 price target.

Analyst Timm Schulze-Melander issued the bullish rating with Apple shares at $305.61, implying approximately 31% upside to the new target.

The upgrade comes as investor attention increasingly shifts toward Apple’s ability to monetize artificial intelligence across its enormous installed device base. Apple remains uniquely positioned within the technology sector because of the combination of its premium hardware ecosystem, high-margin Services business and ability to integrate AI capabilities directly across iPhone, Mac and other devices.

A $400 target also suggests Rothschild & Co Redburn sees room for Apple’s valuation to remain elevated as the company enters its next product and AI cycle.

The rating change is particularly notable because it represents an outright upgrade rather than simply an increase in the price target. Moving from Neutral to Buy signals a materially more constructive view of Apple’s risk-reward profile.

With AAPL trading around $305.61 in the rating report, investors will now watch whether improving expectations around AI monetization, Services growth and the broader Apple ecosystem can provide enough earnings growth to justify the analyst’s $400 target.

💬 🔗

European Investor 08-17-26

Apple Stock Falls After Jefferies Downgrade to Underperform

Apple (NASDAQ: AAPL) shares fell about 2.2% Monday after Jefferies Financial Group downgraded the iPhone maker to Underperform from Buy and sharply reduced its price target.

Jefferies analyst Edison Lee lowered the firm's price target on Apple to $263.66 from $285.56. With Apple previously trading around $306.57, the new target implies roughly 14% downside from that level.

Jefferies Turns Bearish on Apple

The downgrade represents a significant shift in Jefferies' view of Apple, moving directly from a bullish Buy recommendation to an Underperform rating rather than stepping down to Neutral.

The substantial reduction in the price target also suggests Jefferies sees Apple's current valuation as difficult to justify relative to its expectations for the company's future earnings and growth.

Monday's approximately 2.2% decline indicates investors are taking the more cautious analyst view seriously, particularly after Apple's recent share-price strength.

Why Is AAPL Stock Down Today?

The Jefferies downgrade appears to be the primary company-specific catalyst behind Monday's decline.

At approximately $306.57 before the move, Apple was trading more than $40 above Jefferies' new $263.66 target. That valuation gap provides a clear explanation for the market's negative reaction.

The downgrade also comes as investors continue to assess Apple's position in artificial intelligence and whether its AI strategy can generate sufficient new revenue and device demand to support its premium valuation.

For now, the combination of a two-notch downgrade and a substantially lower price target is putting pressure on AAPL shares, with investors likely to watch whether other Wall Street analysts become more cautious on Apple's valuation and AI-driven growth expectations.

💬 🔗

European Investor 08-10-26

Load More

11-03-26The Investor

11-03-26The Investor

11-03-26The Investor

11-03-26Global Finance News

11-03-26Global Finance News

Brent CrudeFollow

Track all markets on TradingView - Prices are not updated in real time

Brent Crude Rebounds While Gold Falls as Middle East Tensions Shift Inflation Expectations

Brent crude rose while gold moved sharply lower on Tuesday, as renewed Middle East tensions pushed energy prices higher but also strengthened concerns that inflation could remain elevated.

Brent futures climbed about 1.9% to $106.71 a barrel, reversing part of the previous session’s steep decline. The rebound followed renewed geopolitical tensions involving the U.S. and Iran, which brought supply risks back into focus after hopes for diplomatic progress had reduced the oil market’s risk premium.

Oil prices moved higher after reports of a U.S. strike on Iran’s Qeshm Island, while comments from Iranian officials suggested the two sides remain far apart on a potential agreement. The developments revived concerns over Middle East supply disruptions and restored part of the geopolitical risk premium that had been removed from prices a day earlier. (Reuters)

The move suggests traders are once again pricing in the possibility of disruptions to regional energy flows, particularly if tensions spread to shipping routes or critical oil infrastructure. Brent had fallen sharply a day earlier as expectations for negotiations increased, making Tuesday’s rebound largely a reassessment of those assumptions.

Gold moved in the opposite direction. Futures fell about 1.5% to $3,910.10 an ounce, extending pressure on bullion despite the increase in geopolitical uncertainty.

The decline appears to reflect the inflation and interest-rate implications of higher oil prices. A renewed rise in energy costs can increase inflation expectations and reinforce the case for tighter or more prolonged restrictive monetary policy. Higher interest rates and bond yields generally reduce the relative appeal of non-yielding assets such as gold.

The contrasting moves in Brent and gold highlight how the same geopolitical event can affect asset classes differently. Oil is benefiting directly from renewed supply-risk concerns, while gold is facing pressure from the possibility that higher energy prices could keep inflation and interest rates elevated.

Near-term direction for both markets is likely to remain tied to developments between Washington and Tehran. Further escalation could support crude prices, while gold may continue to depend more heavily on how the conflict affects Treasury yields, the U.S. dollar and expectations for Federal Reserve policy.

💬 🔗

Global Finance News 11-03-26

Brent Crude Falls 3.7% as Iran Peace Talks Ease Immediate Supply Fears

Brent crude fell sharply on Monday, trading around $109.21 a barrel and down about 3.7%, as renewed diplomatic efforts involving Iran and Qatari mediators reduced some of the geopolitical risk premium that had built into oil prices. (The Wall Street Journal)

The decline follows a strong October rally that pushed Brent to its highest level in roughly six months. With no major military escalation over the weekend and negotiations continuing, traders appear to be taking profits and reassessing the probability of further disruption to oil flows through the Strait of Hormuz. (business-standard*com)

However, underlying supply conditions remain tight. Regional disruptions have already depleted global inventories significantly, while diesel stocks remain unusually low in several markets. That means the current decline appears more related to a reduction in geopolitical risk premium and profit-taking than to a fundamental shift toward abundant supply. (Reuters)

The key near-term driver remains the Iran diplomatic process: meaningful progress could push more risk premium out of crude prices, while renewed military escalation could quickly reverse the current selloff.

💬 🔗

The Investor 11-02-26

Brent Crude Falls 1.8% as U.S.-Iran De-Escalation Hopes Ease Supply Fears

Brent crude fell about 1.8% to $109.68 per barrel as renewed hopes for an easing in U.S.-Iran tensions reduced some of the geopolitical risk premium that had recently pushed oil prices higher.

The move also appears to reflect profit-taking after last week’s strong rally, when concerns over Middle East supply disruptions drove crude sharply higher. Traders are now reassessing whether the recent escalation will translate into a lasting hit to oil flows.

Supply risks have not disappeared, however, and continued instability in the region is helping keep Brent elevated above $109 per barrel. That means oil prices remain sensitive to any new developments involving Iran, regional attacks or disruptions to major shipping routes.

Overall, Monday’s decline looks more like a partial unwinding of geopolitical risk premium than a major change in the underlying supply outlook.

💬 🔗

WS News 10-26-26

Brent Crude Jumps Nearly 4% as Middle East Supply Risks and U.S. Gulf Shutdowns Intensify

Brent crude futures surged 3.94% to around $104.15 per barrel on Thursday, extending gains as geopolitical and weather-related supply concerns returned to the forefront of the oil market.

The strongest catalyst is renewed disruption risk around the Strait of Hormuz and the wider Gulf. Shipping activity through Hormuz has fallen sharply following a fresh wave of tanker attacks, increasing concerns over the security of a route that handled roughly one-fifth of global oil and fuel flows before the current conflict. (Reuters)

Supply fears were compounded by production disruptions in the U.S. Gulf of Mexico. Offshore producers have curtailed operations as Hurricane Isaias approaches, temporarily removing part of U.S. oil and gas output from the market. U.S. crude inventories also fell by 3.2 million barrels, adding another supportive factor. (Reuters)

The sharp move above $104 suggests traders are rebuilding a geopolitical risk premium after recent attempts to ease supply pressure through strategic stock releases.

Near term, Brent’s direction will remain highly sensitive to tanker traffic through Hormuz, further attacks on regional energy infrastructure, the duration of Gulf of Mexico production outages and any escalation involving Iran.

💬 🔗

The Investor 10-08-26

Brent crude futures fell 1.34% to $98.98 per barrel in early trading, extending losses after briefly trading above $101 earlier in the session.

Prices moved sharply lower during the morning, slipping below the $100 level and reaching an intraday low near $99.

The move marks a notable reversal from earlier gains, with Brent giving up more than $2 per barrel from its session high.

💬 🔗

Global Finance News 10-06-26

Brent Crude Holds Above $102 After Sharp Intraday Volatility

Brent crude futures traded around $102.14 per barrel on Monday, down 0.11%, after a highly volatile early session.

Prices initially fell below $101 before rebounding sharply and briefly moving above $103 per barrel. Brent later gave back part of the advance but remained comfortably above the session’s early lows.

The price action suggests the oil market remains highly sensitive to shifting supply and geopolitical expectations. The rapid rebound from below $101 indicates buyers are still emerging aggressively on dips, while the pullback from above $103 shows resistance at higher levels.

Near term, the $103 area appears to be an important upside level, while the roughly $101–$102 range could provide support if volatility persists. The broader direction will remain heavily dependent on developments affecting global supply expectations and Middle East risk.

💬 🔗

European Investor 10-05-26

U.S. Crude Inventories Rise as Atlanta Fed GDPNow Estimate Drops to 3.7%

U.S. crude oil inventories increased by 922,000 barrels in the latest weekly report, contrary to expectations for a 700,000-barrel decline. The previous reading showed a much larger 2.969 million-barrel build.

Inventories at Cushing, Oklahoma, also rose by 553,000 barrels after increasing by 2.266 million barrels previously, adding to signs of a looser near-term crude supply balance.

Separately, the Atlanta Fed’s GDPNow estimate for third-quarter U.S. economic growth fell sharply to 3.7% from 5.0%. The previous estimate had also stood at 5.0%.

For markets, the inventory build is a negative signal for crude prices because it suggests supply exceeded expectations during the week. At the same time, the lower GDPNow estimate points to softer expected economic growth, which could further weigh on oil demand expectations while supporting expectations for a less restrictive Federal Reserve stance.

💬 🔗

Global Finance News 09-30-26

Brent Crude Rises 1.6% as U.S.-Iran Talks Stall and Hormuz Risks Persist

Brent crude futures rose 1.6% to around $99 a barrel on Monday as geopolitical risk returned to the market following another setback in U.S.-Iran negotiations.

Oil prices gained after U.S. President Donald Trump rejected Iran’s latest proposal aimed at reopening the Strait of Hormuz, while both sides remained open to further talks. The unresolved dispute has kept a geopolitical premium in crude because the waterway remains critical to Gulf oil exports.(thenationalnews*com)

At the same time, supply concerns are being partly offset by improving regional export flows. Middle East crude exports are on track to reach about 12.8 million barrels per day in September, their highest level since the conflict began, while shipments through Hormuz have also recovered significantly from earlier disruptions.(Iran International)

Saudi Arabia’s East-West pipeline has also restarted after being damaged earlier this month, providing another route for crude exports and limiting some of the upside pressure on prices. (Reuters)

The result is a highly volatile oil market: geopolitical tensions continue to support Brent, while improving Gulf exports and alternative Saudi shipping routes are preventing supply fears from escalating further.

💬 🔗

The Investor 09-28-26

Brent Crude Climbs Back Above $100 as U.S.-Iran Tensions Revive Supply Concerns

Brent crude futures rose 2.08% to $100.16 a barrel on Thursday as renewed concerns over Middle East supply risks outweighed recent optimism around improving Gulf exports.

Oil prices rebounded after hopes for a quick U.S.-Iran diplomatic breakthrough faded. Talks surrounding the UN General Assembly produced limited progress, while uncertainty remained over the reopening of the Strait of Hormuz, a critical route for global crude shipments. (The National)

The move reverses part of Brent’s recent decline. Earlier this week, prices had fallen below $100 as Saudi Arabia restarted its East-West pipeline and markets anticipated increased exports through the Red Sea, while expectations for U.S.-Iran negotiations reduced the geopolitical risk premium. (FXStreet)

Supply concerns have not disappeared, however. Restrictions around Hormuz remain a major risk, while tight refined-product markets—particularly diesel—are adding support to crude prices. (Kitco)

Near-term direction is likely to remain highly sensitive to developments between Washington and Tehran, shipping flows through Hormuz and the pace of Saudi supply normalization.

💬 🔗

European Investor 09-24-26

Brent Crude Falls 1.1% as Saudi Pipeline Restarts and Hormuz Reopening Hopes Pressure Prices

Brent crude futures fell 1.14% to around $99.20 a barrel Tuesday, extending recent weakness as improving Middle East supply prospects reduced some of the geopolitical risk premium in oil prices.

The biggest pressure came from Saudi Arabia’s East-West Pipeline. The kingdom has restarted operations after the route was shut following drone attacks, and exports from the Red Sea port of Yanbu could resume. The pipeline had been used to reroute roughly 4 million barrels per day around the Strait of Hormuz, making its restart an important development for regional supply. (Reuters)

Oil prices also weakened after Iran signaled that the Strait of Hormuz could reopen within seven days if the U.S. eases military pressure and lifts its blockade on Iranian ports. The possibility of renewed diplomacy has reduced fears of a prolonged disruption through one of the world’s most important oil transit routes. (Reuters)

At the same time, physical supply flows appear to be adapting. Middle Eastern exporters have increasingly used alternative routes and storage hubs, while Saudi shipments have remained stronger than initially feared.

Still, downside risks are not one-sided. Shipping traffic through Hormuz remains far below pre-conflict levels, and continued regional fighting means oil could remain volatile even if supply conditions improve further.

💬 🔗

WS Investor 09-22-26

Load More

11-03-26Global Finance News

11-03-26Global Finance News

11-02-26The Investor

10-15-26The Investor

10-15-26The Investor

NASDAQ:PLTRFollow

Track all markets on TradingView - Prices are not updated in real time

Palantir Falls 5% Premarket Despite Explosive Q3 Growth as Valuation and Expectations Overshadow Results

Palantir Technologies (NASDAQ: PLTR) shares fell about 5% in premarket trading despite reporting exceptionally strong third-quarter 2026 growth and raising full-year guidance above prior expectations.

Revenue surged 96% year over year to $2.31 billion and increased 20% sequentially. U.S. revenue rose 119% to $1.94 billion, while U.S. commercial revenue jumped 148% to $984 million and surpassed U.S. government revenue for the first time in company history. U.S. government revenue increased 96% to $953 million.

Profitability remained unusually strong for a company growing at this pace. GAAP operating income reached $1.08 billion, representing a 47% margin, while adjusted operating income was $1.43 billion, or a 62% margin. Adjusted free cash flow totaled $1.22 billion, equivalent to a 53% margin.

Palantir also continued to show strong deal activity, closing 212 contracts worth at least $1 million during the quarter. U.S. commercial remaining deal value increased 79% year over year to $6.52 billion.

The company raised full-year 2026 revenue guidance to $8.530-$8.534 billion and now expects U.S. commercial revenue growth of at least 143%. Adjusted operating income guidance was increased to $5.245-$5.249 billion, while adjusted free cash flow guidance rose to $4.8-$5.0 billion.

The 5% premarket decline appears to reflect the exceptionally high expectations already embedded in Palantir’s valuation rather than any obvious deterioration in fundamentals. Even with 96% revenue growth, rising margins and another guidance increase, investors may have been positioned for an even larger upside surprise. The reaction suggests that at current valuation levels, very strong results alone may not be enough to drive further gains unless growth and guidance materially exceed already aggressive expectations.

💬 🔗

Global Finance News 11-03-26

Palantir Elevates Aplos Data to Vanguard: Elite to Expand Foundry and AIP Deployments

Palantir Technologies (NASDAQ: PLTR) named Aplos Data to Vanguard: Elite, the highest tier of its trusted partner network, expanding the firm’s role from implementing Palantir for existing customers to helping bring Foundry and AIP to new customers across the United States.

The designation reflects Aplos Data’s deployment track record, with Palantir citing the company’s ability to move projects into production quickly and deliver measurable operational outcomes. Aplos was built specifically around Palantir’s platform and includes founders with prior recognition from Palantir’s developer community.

Under the expanded relationship, Aplos will support new customer acquisition as well as implementation, using its “Operate as One” methodology to integrate systems, data and decision-making into unified operating environments on Palantir.

The companies highlighted deployments at Mansfield Energy and Surf Air Mobility. At Mansfield, Aplos is helping expand the use of Foundry across operations, while at Surf Air it has supported development of SurfOS, the company’s digital infrastructure platform for aviation operations.

Aplos also demonstrated a fuel-distribution application at Palantir’s AIPCon 11 that monitors thousands of diesel tanks, predicts when fuel will run low and automatically places orders, leaving staff to intervene only on exceptions requiring human judgment.

The announcement strengthens Palantir’s partner ecosystem and could help broaden adoption of Foundry and AIP by giving new customers access to specialized implementation capacity focused exclusively on Palantir deployments.

💬 🔗

European Investor 10-22-26

Palantir Stock Rises 2.8% After Goldman Sachs and Raymond James Upgrades

Palantir shares rose about 2.8% to $199.60 after receiving two analyst upgrades, with Goldman Sachs moving the stock to Buy from Neutral and setting a $230 price target, while Raymond James upgraded shares to Outperform from Market Perform.

Goldman’s more bullish view centers on expectations that Palantir could enter another phase of outperformance into 2027. The firm sees the company’s total addressable market expanding as demand grows around sovereign AI, bespoke applications and Palantir’s verticalization strategy.(Yahoofinance)

Goldman also highlighted Palantir’s ability to connect its field engineering teams with product development, creating a feedback loop that helps customers build customized software applications and allows Palantir to scale those capabilities more efficiently.(Yahoofinance)

The stock is now trading close to its prior record high, suggesting investors are increasingly willing to pay for the prospect of another leg of growth despite Palantir’s already elevated valuation.

💬 🔗

European Investor 10-08-26

Palantir and Fujitsu Expand Partnership to Accelerate Enterprise AI Adoption

Palantir Technologies and Fujitsu have expanded their strategic partnership to accelerate enterprise AI adoption in Japan and global markets, with Fujitsu becoming a Global Forward Deployed Engineering (FDE) Partner.

Under a new agreement with Palantir Technologies Japan, Fujitsu will expand its use of Palantir’s Artificial Intelligence Platform (AIP) and Foundry while investing in FDE capabilities. The partnership will focus particularly on sovereign AI, allowing enterprises to deploy AI applications while maintaining greater control over their data, models, infrastructure and operations.

The companies highlighted an existing deployment in which Fujitsu used Palantir technology to build a supply-chain resilience system for a major Japanese manufacturer. The platform integrated information from more than 3,000 suppliers and 18 factories, generating more than $10 million in cost savings within one year while doubling operational productivity.

Fujitsu plans to combine Palantir AIP and Foundry with its own technologies, including its Takane large language model and Uvance offerings, to develop customized enterprise AI applications.

The expanded agreement builds on a strategic relationship dating to 2020 and comes as Palantir broadens its enterprise AI ecosystem.

💬 🔗

The Investor 09-10-26

NVIDIA and Palantir Partner to Bring Sovereign AI to Critical Supply Chains

NVIDIA and Palantir Technologies announced a new collaboration Thursday to develop a sovereign AI stack designed to optimize complex supply chains, with the technology initially being deployed across NVIDIA’s own operations.

The platform combines NVIDIA’s Nemotron open AI models with Palantir Foundry and its Artificial Intelligence Platform, or AIP. Grounded in Palantir’s Ontology, the system is designed to identify supply constraints, improve visibility and help organizations make operational decisions while maintaining control of proprietary data.

NVIDIA is using the technology to manage one of the semiconductor industry’s most complicated supply chains. The company said each Vera Rubin rack requires about 1.3 million parts, with production dependent on coordinated supplies of compute, memory, networking, power, cooling and mechanical components.

The companies plan to extend the technology beyond NVIDIA to industries including manufacturing, energy, healthcare, automotive and aerospace. Customers will be able to deploy the AI stack on-premises, in colocation facilities or in the cloud while retaining ownership and control of their models and operational data.

💬 🔗

The Investor 09-10-26

Palantir and Nebius Partner to Build Sovereign AI Infrastructure for Enterprise Customers

Palantir Technologies (NASDAQ: PLTR) and Nebius Group (NASDAQ: NBIS) announced a strategic partnership aimed at giving Palantir’s commercial customers greater control over the infrastructure, data and models powering their artificial intelligence applications.

Under the agreement, Palantir named Nebius its preferred sovereign AI infrastructure partner. Following an integration period, Nebius compute infrastructure and inference endpoints will be brought inside the Palantir enterprise perimeter, allowing eligible customers to access Nebius cloud and AI infrastructure directly through Palantir’s ecosystem.

The partnership combines Nebius’ AI-native computing platform with Palantir’s Sovereign AI Operating System, which incorporates AIP, Ontology, Foundry and Apollo. Customers will be able to deploy open AI models on Nebius infrastructure and continuously adapt those models using proprietary organizational data while retaining control over their compute, models and information.

The companies also plan to accelerate the deployment of additional AI computing capacity, including modular data centers at locations where power infrastructure is already available. The approach could help address one of the major constraints facing the AI industry: rapidly bringing additional computing capacity online.

For Palantir, the partnership expands the infrastructure available behind its enterprise AI platform. For Nebius, becoming Palantir’s preferred sovereign AI infrastructure partner provides another channel for its rapidly expanding AI cloud and compute business as enterprises increase spending on AI infrastructure.

💬 🔗

The Investor 09-08-26

Palantir and PwC Expand Alliance to Scale Enterprise AI

Palantir Technologies (NASDAQ: PLTR) and PwC US have expanded their strategic alliance to help companies deploy artificial intelligence across core business operations, with an initial focus on enterprise AI, mergers and acquisitions, and ERP modernization.

The collaboration combines Palantir’s Foundry and Artificial Intelligence Platform (AIP) with PwC’s consulting, engineering and industry expertise. The companies aim to help enterprises move AI projects from pilots into production and embed AI into areas such as supply chains, logistics, cybersecurity and customer management.

AI-Native M&A and ERP Transformation

A major part of the expanded partnership is a new AI-native deals IT platform powered by Palantir Foundry and AIP. PwC and Palantir said the platform is designed to help companies execute M&A transactions up to 50% faster while reducing one-time transaction costs by as much as 45%.

The companies will also use Palantir’s AI technology alongside PwC’s SAP expertise to improve data quality and reduce risks during ERP transformations.

For Palantir, the expanded PwC relationship could broaden enterprise adoption of its AI software by combining its technology with PwC’s large corporate client base and implementation capabilities. The agreement also strengthens Palantir’s position in the growing enterprise AI market, where companies are increasingly shifting from experimental AI projects toward production-scale deployments.

💬 🔗

The Investor 09-04-26

Palantir Wins U.S. Army Contract to Deliver Eight AI-Powered TITAN Systems

Palantir Technologies (NASDAQ: PLTR) has secured a new U.S. Army contract to produce and deliver eight Tactical Intelligence Targeting Access Node, or TITAN, systems, expanding the company’s role in the military’s deployment of artificial intelligence and next-generation battlefield intelligence technology.

The agreement, awarded by Army Contracting Command to Palantir’s USG subsidiary, covers four Advanced and four Basic TITAN systems. The Advanced version provides greater processing and integration capabilities, while the Basic version is designed for mobility and rapid deployment. Financial terms of the contract were not disclosed.

TITAN is an AI- and machine learning-enabled ground station designed to process data from space, high-altitude, aerial and terrestrial sensors. The system converts that information into actionable targeting intelligence that can support mission command and long-range precision fires.

Palantir will serve as the prime contractor, overseeing manufacturing and delivery of the complete systems while providing the software that powers TITAN. The platform also integrates technologies from defense and technology partners including Anduril Industries, L3Harris Technologies, Sierra Nevada Corporation, Strategic Technology Consulting and World Wide Technology.

The new award moves TITAN beyond its earlier prototype phase and further into production and operational deployment. Palantir will also continue supporting TITAN prototype systems already fielded with Army units while developing future capabilities.

The contract reinforces Palantir’s growing position at the intersection of AI, defense software and battlefield data integration. TITAN is particularly significant because Palantir is not simply supplying analytics software but acting as the prime contractor for an integrated hardware-and-software military system, potentially expanding the scope of opportunities available to the company within the U.S. defense sector.

💬 🔗

The Investor 09-02-26

Palantir Stock Soars 23% After Blowout Q2 Results and Massive Guidance Increase

Palantir Technologies (NASDAQ: PLTR) surged 23% on Tuesday after delivering another blockbuster quarterly report that significantly exceeded Wall Street expectations. The AI software company reported explosive revenue growth, record commercial demand and sharply raised its full-year outlook, reinforcing its position as one of the biggest beneficiaries of accelerating enterprise AI adoption.

Second-quarter revenue jumped 93% year over year to $1.94 billion, while U.S. commercial revenue surged an extraordinary 149% to $764 million. Total U.S. revenue climbed 115% to $1.57 billion, supported by continued strength across both commercial and government customers.

U.S. Commercial Business Continues to Accelerate

The company's commercial momentum remained the key highlight of the quarter. Palantir closed a record $2.13 billion in U.S. commercial total contract value (TCV), up 153% from a year ago, while U.S. commercial remaining deal value increased 124% to $6.24 billion.

Overall, the company closed 220 deals worth at least $1 million during the quarter, including 73 contracts exceeding $10 million. Total contract value reached $3.37 billion, up 49% year over year, highlighting sustained demand for Palantir's AI-driven software platform.

CEO Alex Karp said growing demand for "AI sovereignty" is driving organizations toward platforms that allow customers to retain full control of their data while deploying artificial intelligence at scale.

Profitability and Cash Flow Reach New Highs

Palantir also demonstrated exceptional profitability alongside its rapid growth. GAAP operating income reached $912 million, representing a 47% operating margin, while adjusted operating income climbed to $1.19 billion, or 62% of revenue.

GAAP net income totaled $1.06 billion, with both adjusted free cash flow and cash from operations exceeding $1.2 billion. The company ended the quarter with $9.2 billion in cash, cash equivalents and short-term U.S. Treasury securities, providing significant financial flexibility.

Guidance Raised Well Above Expectations

Management substantially increased its 2026 outlook, now expecting full-year revenue between $8.15 billion and $8.16 billion, representing approximately 82% annual growth. The company also raised its U.S. commercial revenue forecast to more than $3.42 billion, implying at least 134% growth, while increasing adjusted operating income guidance to as much as $4.90 billion.

## What to Watch

Tuesday's rally reflects investor confidence that Palantir remains one of the strongest AI growth stories in the market. Investors will now focus on whether the company can sustain its exceptional commercial growth, continue converting large enterprise contracts into recurring revenue, and maintain its industry-leading profitability as AI adoption accelerates globally.

💬 🔗

European Investor 08-04-26

Palantir (PLTR) Stock Rises After DA Davidson Upgrades Shares to Buy

Palantir Technologies (NASDAQ: PLTR) shares gained approximately 3.5% on Thursday after DA Davidson upgraded the software company to Buy from Neutral and raised its price target to $175 from $165.

The upgrade comes as Palantir continues to benefit from strong investor enthusiasm surrounding artificial intelligence, with the company expanding its presence across both commercial and government markets through its AI-driven software platforms.

DA Davidson upgraded the stock and increased its price target, reflecting a more constructive outlook on the shares. The positive analyst action added to investor optimism surrounding Palantir's long-term growth potential.

Palantir has been one of the strongest performers in the software sector this year as enterprises continue increasing investments in AI applications, data analytics, and automation. The company has also continued to win government contracts while expanding adoption of its Artificial Intelligence Platform (AIP) among commercial customers.

# Why PLTR Stock Rose

Several factors supported the stock:

* DA Davidson upgraded Palantir to Buy from Neutral.
* The firm raised its price target to $175 from $165.
* Continued optimism around enterprise AI adoption and government demand has supported investor sentiment toward Palantir.
* The company remains well positioned to benefit from growing investment in AI-powered software and data analytics.

The combination of a rating upgrade and continued optimism surrounding the AI sector helped lift Palantir shares approximately 3.5% during Thursday's trading session.

💬 🔗

Global Finance News 07-02-26

Load More

11-03-26The Investor

11-03-26Global Finance News

10-09-26WS News

10-08-26European Investor

10-08-26European Investor

NASDAQ:GOOGFollow

Track all markets on TradingView - Prices are not updated in real time

Alphabet Q3 Revenue Jumps 25% as Google Cloud Growth Surges on AI Demand

Alphabet (NASDAQ: GOOG, GOOGL) reported a strong third quarter of 2026, with revenue rising 25% year over year to $127.6 billion, marking its 13th consecutive quarter of double-digit growth.

Google Services revenue increased 11% to $96.3 billion. Google Search & other revenue rose 12% to $63.4 billion, with management saying year-over-year Search query growth reached its fastest pace in five years. YouTube advertising revenue increased to $11.2 billion from $10.3 billion.

Google Cloud was the standout performer, with revenue more than doubling to $30.7 billion from $15.2 billion. Growth was driven by enterprise AI infrastructure, AI solutions, core Google Cloud Platform services and TPU systems. Cloud operating income surged to $11.1 billion from $3.6 billion.

Alphabet’s operating income increased 30% to $40.6 billion, with operating margin improving to 31.8%. However, net income fell to $26.2 billion from $35.0 billion, while diluted EPS declined to $2.12 from $2.87, largely reflecting an $8.2 billion net other expense compared with $12.8 billion of other income a year earlier.

AI adoption continued to accelerate. Alphabet said its first-party model APIs are processing nearly 32 billion tokens per minute, more than four times the year-ago level, while the Gemini app has surpassed one billion users.

Overall, the quarter showed exceptionally strong momentum in Google Cloud and continued resilience in Search, with AI investment translating into faster revenue growth and sharply higher cloud profitability despite the year-over-year decline in reported net income.

💬 🔗

Global Finance News 11-01-26

Google Launches Workplace AI Agent That Acts Like Colleague

💬 🔗

WS News 10-08-26

Meta’s Muse Could Be the Biggest Threat Google Has Faced in 20 Years

Meta’s Muse could challenge Google’s $63 billion Search business by replacing searches, clicks, and ads with AI-driven decisions and transactions.

(finance.yahoo.com)

💬 🔗

WS News 09-28-26

Accenture and Google Cloud Team With Volvo Cars on AI-Powered Automotive Software Platform

Accenture and Google Cloud said Volvo Cars has become the lead industry partner for Horizon, an open-source software development platform designed to help automakers build, test and deploy Android Automotive OS software faster.

Volvo Cars is migrating its global AAOS development environment to Horizon, which combines cloud-native development tools, virtual testing environments and AI-assisted workflows. The platform is intended to shorten development cycles and give engineering teams more time to focus on in-car digital experiences.

Accenture and Google Cloud said Horizon can deliver up to 9x faster software testing using virtual Android Automotive environments, reduce infotainment feature development costs by up to 40%, and cut build feedback times from as much as two hours to minutes. The platform also supports remote access to virtual and physical device farms and faster onboarding through virtual workbenches.

The companies said insights from the Volvo collaboration will help refine Horizon and expand its generative AI capabilities for other automakers and industrial manufacturers. Accenture, Google Cloud and Volvo are already working to extend the platform to additional organizations and markets.

The partnership highlights the growing shift toward software-defined vehicles, where faster development, virtual validation and AI-assisted engineering are becoming increasingly important competitive capabilities.

💬 🔗

Global Finance News 09-22-26

NVIDIA, Google and Emerald AI Launch Alliance to Tackle AI Data Center Power Constraints

NVIDIA, Google and Emerald AI have launched the AI Energy Management Alliance, a new coalition aimed at making large AI data centers more flexible in how they consume electricity and accelerating their connection to power grids.

Power availability has become a major constraint on the expansion of U.S. AI infrastructure. The alliance is developing a framework that would allow AI data centers to adjust electricity consumption according to grid conditions by shifting computing workloads, using energy storage or paired generation, and reducing demand during periods of system stress.

The approach could allow utilities to connect large AI facilities more quickly while reducing the need for costly grid upgrades. AEMA plans to establish standardized performance requirements covering response times, power curtailment, emergency operations and data sharing between data centers and grid operators.

The initiative brings together AI companies, data center operators, power producers, utilities and grid operators. For NVIDIA and the broader AI industry, addressing electricity constraints is becoming increasingly important as rapidly expanding AI computing capacity requires substantially more power infrastructure.

💬 🔗

WS Investor 09-16-26

European antitrust rulings reshape Google’s comparison shopping ecosystem | Noah Intelligence

New regulations and legal challenges are disrupting Google's dominance in comparison shopping services across Europe, prompting calls for increased fairness among merchants and rivals.A comparison shopping service, or...

(noah-news.com)

💬 🔗

WS Investor 09-14-26

Regulators target transparency in digital ad auctions amid Google and Amazon cases | Noah Intelligence

Recent legal actions against Google and Amazon spotlight growing concerns over auction fairness and transparency in digital advertising, raising questions about platform control and trust.The latest legal scrutiny of...

(noah-news.com)

💬 🔗

The Investor 09-12-26

Alphabet (GOOGL) Stock Edges Higher After Morgan Stanley Raises Price Target

Alphabet (NASDAQ: GOOGL) shares traded modestly higher on Tuesday after Morgan Stanley raised its price target on the Google parent company, reinforcing confidence in its long-term growth prospects driven by artificial intelligence and digital advertising.

The brokerage maintained its Overweight rating while increasing its price target to $415 from $375, signaling continued optimism about Alphabet's ability to capitalize on AI-driven opportunities across its search, cloud, and software businesses.

# Morgan Stanley Sees More Upside

The higher price target reflects growing confidence that Alphabet will continue benefiting from expanding AI adoption while maintaining its leadership in digital advertising.

Analysts also remain constructive on the company's cloud business, where ongoing investment in generative AI services is expected to support revenue growth and margin expansion over the coming years.

# AI Remains a Key Growth Driver

Alphabet has accelerated the rollout of AI-powered products across Google Search, Google Cloud, and Workspace, while continuing to invest heavily in infrastructure to support growing enterprise and consumer demand.

The company's strong balance sheet and leadership in AI innovation continue to position it as one of the largest beneficiaries of the industry's long-term growth.

# Why GOOGL Stock Was Little Changed

Despite the higher price target, Alphabet shares posted only modest gains, suggesting much of the positive outlook may already be reflected in the stock's valuation.

Still, Morgan Stanley's decision to reaffirm its Overweight rating while lifting its valuation target reinforces Wall Street's confidence in Alphabet's long-term earnings potential and competitive position within the AI ecosystem.

💬 🔗

Global Finance News 06-30-26

Alphabet Falls 5% Despite Citi Reiterating Positive Rating

Alphabet (NASDAQ: GOOG) fell 5% even after Citigroup reiterated its Market Outperform rating, as investors reacted to broader concerns surrounding competition, valuation, and the evolving artificial intelligence landscape.

The decline came despite Citi maintaining a positive long-term view on the company. Alphabet remains one of the world's dominant digital advertising and cloud computing platforms, with growing exposure to artificial intelligence through products such as Gemini and its expanding AI infrastructure investments.

However, investor sentiment toward the stock has recently become more cautious as competition in AI-powered search intensifies. Market participants continue to evaluate how generative AI could reshape internet search and digital advertising, two of Alphabet's most important businesses.

Despite the sharp decline, analysts generally remain constructive on Alphabet's outlook. The company's leadership positions in search, cloud computing, digital advertising, and artificial intelligence continue to provide multiple growth drivers. Google Cloud has also emerged as a key beneficiary of growing enterprise AI adoption, helping diversify revenue beyond advertising.

Citigroup's reaffirmed Market Outperform rating suggests the firm believes the recent weakness does not alter Alphabet's long-term investment case. Nevertheless, the stock's decline highlights that investors remain sensitive to competitive developments and AI-related execution risks across the technology sector.

💬 🔗

Global Finance News 06-22-26

Alphabet Holds Steady as TD Cowen Raises Price Target to $475

Alphabet (GOOG) traded little changed despite receiving a bullish analyst update from TD Cowen, which raised its price target to $475 from $450 while maintaining a Buy rating.

The higher target reflects growing confidence in Alphabet's ability to capitalize on the artificial intelligence boom while maintaining the strength of its core Search and advertising businesses. Investors have become increasingly optimistic that Google's AI investments are beginning to translate into stronger product offerings, improved user engagement, and new monetization opportunities across Search, Cloud, YouTube, and Workspace.

The lack of a significant stock reaction suggests that investors had already been expecting positive analyst commentary following the company's recent execution and strong positioning within the AI ecosystem. Alphabet has been one of the major beneficiaries of increasing enterprise AI adoption, particularly through Google Cloud, which continues to gain traction among businesses deploying large-scale AI workloads.

Analysts remain focused on several key catalysts, including the pace of Google Cloud growth, AI-driven improvements in Search, expansion of advertising revenue, and the company's ability to convert its massive AI investments into sustainable earnings growth.

While the stock was flat on the day, the target increase reinforces the view that many Wall Street firms continue to see substantial upside potential in Alphabet. With the new $475 target standing well above the current share price, TD Cowen's update suggests confidence that Alphabet's combination of AI leadership, dominant digital advertising position, and growing cloud business can continue to drive long-term shareholder returns.

💬 🔗

Global Finance News 06-09-26

Load More

11-03-26Global Finance News

10-26-26Global Finance News

10-08-26The Investor

10-07-26European Investor

10-06-26The Investor

NYSE:BRFollow

Track all markets on TradingView - Prices are not updated in real time

Broadridge Reaffirms FY27 Outlook as Recurring Revenue Grows 11%

Broadridge Financial Solutions (NYSE: BR) reported a solid start to fiscal 2027, with double-digit recurring revenue growth and stronger closed sales, while profitability was pressured by lower event-driven revenue and higher expenses.

First-quarter recurring revenue increased 11% to $1.08 billion, including 9% organic growth. Total revenue rose 5% to $1.67 billion, while closed sales increased 10% to $36 million.

Adjusted EPS rose 3% to $1.56 from $1.51. However, adjusted operating income declined 9% to $230 million and adjusted operating margin fell to 13.8% from 15.8%. GAAP operating income decreased 8% to $174 million.

The Investor Communication Solutions segment posted 10% recurring revenue growth, helped by regulatory and data-driven fund solutions. However, event-driven revenue fell 41% to $67 million, largely due to lower mutual fund proxy activity.

Global Technology and Operations remained stronger. Recurring revenue increased 12% to $516 million, or 13% at constant currency, while pre-tax earnings rose 47% to $99 million. Capital Markets recurring revenue grew 17%, supported by organic growth and the CQG acquisition.

Broadridge reaffirmed its fiscal 2027 guidance for 6%-8% recurring revenue growth at constant currency, 8%-12% adjusted EPS growth, adjusted operating margin of about 21% and closed sales of $290 million-$330 million.

The company also continued returning capital to shareholders, repurchasing $200 million of stock during the quarter and paying $111 million in dividends.

💬 🔗

The Investor 11-03-26

Broadridge Expands Digital Asset Platform to U.S. Wealth Management Firms

Broadridge has expanded its next-generation digital assets platform to the U.S., enabling wealth managers to offer cryptocurrencies and tokenized securities alongside traditional investments through a unified operating model.

The platform, already available in Canada, will serve U.S. broker-dealers, registered investment advisers and wealth managers. Anchorage Digital and Galaxy Digital are among the initial infrastructure providers supporting the offering, with services spanning custody, wallets, liquidity and compliance.

Broadridge’s platform supports cryptocurrencies as well as tokenized real-world assets, including equities, funds and private investments. It accommodates both advisor-led and self-directed investing while integrating with existing recordkeeping systems, regulatory reporting, tax, governance and compliance processes.

The expansion is designed to make it easier for wealth managers to integrate digital assets into their existing operations rather than maintaining separate infrastructure for crypto and traditional investments. Broadridge’s DLX tokenization platform also supports issuance, trading, financing, settlement and servicing of tokenized securities.

Broadridge said its Distributed Ledger Repo platform currently tokenizes more than $351 billion in real assets per day, highlighting the growing institutional scale of its digital asset infrastructure.

💬 🔗

WS Investor 09-14-26

Broadridge Launches DLX Platform for 24/7 Tokenized Financial Markets

Broadridge Financial Solutions (NYSE: BR) launched DLX, a new digital asset infrastructure platform designed to connect traditional financial markets with tokenized and blockchain-based markets.

The platform provides financial institutions with multi-chain connectivity, programmable smart contracts and 24/7 transaction capabilities. It supports the full lifecycle of tokenized assets, including issuance, trading, settlement, servicing, custody, governance and distribution across asset classes such as bonds, equities, funds, private-market assets and money-market instruments.

DLX builds on Broadridge’s existing Distributed Ledger Repo platform, which already processes more than $350 billion in daily activity. The new platform expands that infrastructure beyond repo and collateral markets into a broader range of tokenized financial assets.

Broadridge said DLX can integrate tokenized activity with existing institutional workflows while supporting self-custody, third-party custody and hybrid models, reducing the complexity financial firms face when operating across traditional and blockchain infrastructure.

💬 🔗

WS Investor 09-09-26

Broadridge Expands Tokenized Repo Platform to G7 Securities as Daily Volume Reaches $351 Billion

Broadridge Financial Solutions (NYSE: BR) is expanding its Distributed Ledger Repo platform to support G7 securities, extending its blockchain-based infrastructure into international repo and collateral markets. The expansion will allow institutions to conduct cross-border repo transactions, intraday financing and collateral movements using atomic settlement.

The platform, known as DLR, is already operating at significant institutional scale. During August 2026, it processed an average of $351 billion in repo transactions per day and $7.4 trillion for the full month, with thousands of transactions passing through the network daily. Until now, the platform has supported tokenized U.S. Treasury collateral for repo transactions, intraday repos and collateral pledges.

Adding G7 securities significantly broadens the collateral institutions can mobilize through the platform. DLR synchronizes the movement of tokenized securities and cash in a single transaction, known as atomic settlement, reducing settlement risk while allowing financial institutions to manage liquidity, funding and high-quality collateral more efficiently.

The expansion is particularly significant because it moves institutional tokenization beyond U.S. Treasury markets into cross-border financing. Institutions can use eligible securities across different markets, currencies and jurisdictions while gaining faster settlement, improved visibility into collateral positions and reduced reliance on manual processing.

Broadridge is already one of the largest infrastructure providers bridging traditional finance and tokenized markets. Its DLR platform tokenizes more than $351 billion of assets daily, while Broadridge’s broader technology infrastructure underpins an average of more than $18 trillion in daily trading across tokenized and traditional securities.

The G7 expansion strengthens Broadridge’s position in institutional blockchain infrastructure as major financial institutions increasingly explore tokenization to improve collateral mobility, reduce settlement friction and make capital more efficient.

💬 🔗

The Investor 09-02-26

Broadridge Financial Solutions, Inc. (NYSE:BR) announced that its Board of Directors has declared a quarterly cash dividend of $0.88 per share. The dividend is payable on July 2, 2025 to stockholders of record at the close of business on June 12, 2025.

💬 🔗

The Investor 05-13-25

Broadridge Financial Solutions reported strong second-quarter fiscal 2025 results, with recurring revenues increasing by 9% (constant currency) and total revenues rising by 13% to $1.59 billion. Operating income grew by 69% to $211 million, while adjusted operating income rose 51% to $263 million. The company’s diluted EPS surged by 103% to $1.20, with adjusted EPS increasing by 70% to $1.56.

The company reaffirmed its full-year fiscal 2025 guidance, expecting 6-8% recurring revenue growth (constant currency), 8-12% adjusted EPS growth, and closed sales between $290 million and $330 million. CEO Tim Gokey highlighted Broadridge’s continued execution on its strategy to modernize financial services and leverage long-term trends such as increased investor participation.

Key segment results:
Investor Communication Solutions (ICS) total revenues grew 15% to $1.15 billion, driven by strong recurring and event-driven revenues.
Global Technology and Operations (GTO) recurring revenues increased 9% to $440 million, supported by organic growth and the acquisition of SIS.

Broadridge completed its $185 million acquisition of Kyndryl’s Securities Industry Services (SIS) in November 2024, expanding its wealth management and capital markets offerings in Canada.

The company will hold an investor call today at 8:30 a.m. ET, with a live webcast available on its Investor Relations website.

💬 🔗

WS Investor 01-31-25

Load More

NYSE:PFEFollow

Track all markets on TradingView - Prices are not updated in real time

Pfizer Slips 0.8% Despite Strong Q3 Execution and Raised 2026 Guidance

Pfizer (NYSE: PFE) shares fell about 0.75% despite reporting solid third-quarter 2026 results and raising both its full-year revenue and adjusted EPS guidance.

Third-quarter revenue was $16.6 billion, roughly flat year over year on an operational basis. Excluding Comirnaty and Paxlovid, revenue increased 7% operationally, while launched and acquired products grew 32%, highlighting stronger momentum across Pfizer’s newer portfolio.

Reported net income fell 8% to $3.24 billion, while reported EPS declined to $0.56 from $0.62. Adjusted EPS was unchanged at $0.87, and adjusted income increased slightly to $4.99 billion.

Pfizer raised its 2026 revenue guidance to $62.0 billion-$64.0 billion from $60.5 billion-$62.5 billion, increasing the midpoint by $1.5 billion. The company also raised and narrowed adjusted EPS guidance to $2.95-$3.05 from $2.80-$3.00.

The outlook includes a $650 million acquired in-process R&D charge related to the Innovent Biologics collaboration, which reduced earnings by roughly $0.10 per share. Pfizer also increased its R&D expense outlook to $10.8 billion-$11.8 billion.

The 0.75% decline appears to reflect a market reaction that is more cautious than the headline results suggest. While guidance was raised and non-COVID products continued to grow, total quarterly revenue remained essentially flat and adjusted EPS showed no year-over-year growth. Investors may also be weighing the higher R&D spending required to support Pfizer’s late-stage pipeline against the improving commercial momentum.

💬 🔗

The Investor 11-03-26

Pfizer Declares $0.43 Fourth-Quarter Dividend, Extending Long-Running Payout Streak

Pfizer (NYSE: PFE) said its board of directors approved a fourth-quarter 2026 cash dividend of $0.43 per share.

The dividend will be payable on December 7, 2026, to shareholders of record at the close of business on November 6.

Pfizer said maintaining — and over the longer term growing — its dividend remains part of the company’s capital allocation strategy.

The payment will mark Pfizer’s 352nd consecutive quarterly dividend, extending the pharmaceutical company’s decades-long record of regular shareholder distributions.

💬 🔗

The Investor 10-06-26

Pfizer Reports Positive Phase 3 LITFULO Results in Nonsegmental Vitiligo

Pfizer reported positive Phase 3 results for LITFULO, or ritlecitinib, showing significant improvements in facial and total-body repigmentation in patients with nonsegmental vitiligo.

Across the TRANQUILLO 2 and TRANQUILLO trials, LITFULO significantly outperformed placebo at Week 52. In TRANQUILLO 2, 21.86% of patients receiving 100 mg LITFULO achieved at least 75% improvement in facial vitiligo compared with 2.40% on placebo. In TRANQUILLO, 12.47% of patients receiving 50 mg achieved the same endpoint versus 2.48% with placebo.

For total-body repigmentation, 13.02% of patients in TRANQUILLO 2 and 8.98% in TRANQUILLO achieved at least 50% improvement, compared with 2.40% and 1.98% on placebo, respectively. Improvements were evident from Week 24 and continued through Week 52.

The safety profile remained consistent with LITFULO’s established profile in alopecia areata, with no new safety signals identified.

The two Phase 3 studies enrolled a combined 2,174 patients, making the program the largest late-stage evaluation to date of an oral systemic therapy for nonsegmental vitiligo. Pfizer plans to submit the data to regulators including the FDA and EMA.

The results could broaden LITFULO’s commercial opportunity beyond alopecia areata by positioning the once-daily oral JAK3 and TEC kinase inhibitor as a potential systemic treatment for vitiligo.

💬 🔗

Global Finance News 10-02-26

Pfizer’s Tilrekimig Shows Strong Skin Clearance in Phase 2 Atopic Dermatitis Study

Pfizer reported positive Phase 2 results for tilrekimig, an investigational trispecific antibody being developed for moderate-to-severe atopic dermatitis. The study met its primary endpoint, with all evaluated doses producing statistically significant improvements in EASI-75 skin-clearance rates versus placebo at Week 16.

In Stage 1, 62.5% of patients receiving tilrekimig 450 mg every two weeks achieved EASI-75, compared with 19.9% for placebo. In Stage 2, EASI-75 rates were 58.5% for the 400 mg monthly dose, 61.0% for 200 mg and 47.8% for 50 mg, versus 9.1% for placebo.

Tilrekimig is designed to simultaneously block IL-4, IL-13 and TSLP, targeting multiple pathways involved in type 2 inflammation. Pfizer is also developing the drug with an extended half-life intended to support monthly dosing.

Secondary and exploratory endpoints were also encouraging. Around 26% to 30% of treated patients achieved clear or almost-clear skin depending on dose and study stage, while itch reduction was meaningfully greater than with placebo.

Pfizer said the treatment was generally well tolerated, with no dose-dependent safety signals and no treatment-related serious adverse events reported in the first two stages.

The company has already started Phase 3 trials in atopic dermatitis and asthma and is advancing a Phase 2b/3 study in COPD, positioning tilrekimig as a potentially important next-generation asset in Pfizer’s inflammation and immunology pipeline.

💬 🔗

WS Investor 10-01-26

Pfizer and BioNTech Win FDA Approval for Updated XFG COVID-19 Vaccine

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) received U.S. FDA approval for their updated 2026–2027 COMIRNATY COVID-19 vaccine targeting the XFG variant.

The updated vaccine is approved for adults aged 65 and older and for people aged 5 to 64 who have at least one underlying condition that increases their risk of severe COVID-19. The XFG formulation follows FDA guidance aimed at more closely matching currently circulating variants.

According to the companies, supporting data showed strong immune responses against several circulating SARS-CoV-2 variants, including XFG, XFG.1.1, NB.1.8.1, PQ.17 and PQ.2.8.1. Pfizer and BioNTech said shipments will begin immediately, with the vaccine expected to reach U.S. pharmacies, hospitals and clinics within days.

The approval is commercially positive for both companies because it keeps their COVID-19 vaccine franchise positioned for the upcoming U.S. vaccination season. However, the financial impact will ultimately depend on vaccination rates and demand for updated COVID-19 shots.

💬 🔗

European Investor 08-28-26

Pfizer and Valneva Lyme Disease Vaccine Application Accepted for EMA Review

Pfizer (NYSE: PFE) and Valneva (NASDAQ: VALN) announced Friday that the European Medicines Agency has validated the Marketing Authorization Application for their experimental Lyme disease vaccine, marking a significant regulatory milestone for the program.

The EMA validation means the agency will now begin formally assessing PF-07307405, a six-valent vaccine designed to prevent Lyme disease in people aged five years and older. The application is supported by results from the Phase 3 VALOR trial.

## Phase 3 Trial Shows More Than 70% Efficacy

In the VALOR trial, the vaccine demonstrated efficacy of more than 70% in preventing Lyme disease and was generally well tolerated, with no safety concerns identified. The randomized study included 9,437 participants aged five and older across the U.S., Canada and Europe.

PF-07307405 targets six variants of outer surface protein A, or OspA, found on the Borrelia bacteria responsible for Lyme disease. The approach is designed to generate antibodies that prevent the bacteria from being transmitted from an infected tick to a vaccinated person.

Potential First Lyme Disease Vaccine Currently Available to Humans

The regulatory milestone could be commercially significant because there are currently no approved human vaccines against Lyme disease. Pfizer and Valneva's candidate is the most advanced Lyme disease vaccine currently in clinical development, with two pivotal Phase 3 studies completed. ([Pfizer][1])

The potential market is substantial. Pfizer said more than 200 million people live in Lyme disease risk areas in Europe, while approximately 132,000 cases are reported annually across European countries with surveillance systems.

Pfizer and Valneva have jointly developed the vaccine under a collaboration established in 2020. If regulatory approval is ultimately secured, Pfizer will be responsible for manufacturing and commercializing the product.

EMA validation does not constitute approval, but it confirms that the application is sufficiently complete to enter the formal regulatory review process. The next major catalyst for the program will therefore be the outcome of the EMA assessment.

💬 🔗

Global Finance News 08-14-26

Pfizer Stock Slips 0.54% Despite Higher Revenue Guidance and Strong Product Growth

Pfizer (NYSE: PFE) shares slipped 0.54% on Tuesday despite reporting solid second-quarter results, raising the midpoint of its full-year revenue guidance and highlighting continued momentum from its newer product portfolio and late-stage pipeline.

Second-quarter revenue increased 3% year over year to $15.0 billion, while operational revenue growth reached 1%. Excluding COVID-19 products Comirnaty and Paxlovid, operational revenue grew 5%, supported by strong performance from recently launched and acquired products, which posted 18% operational growth. Pfizer reported a GAAP loss per share of $0.04 and adjusted EPS of $0.77, with reported results impacted by $4.3 billion in non-cash intangible asset impairment charges.

Growth Portfolio Continues to Offset COVID Declines

Pfizer's underlying business continued to strengthen as growth from key products more than offset declining COVID-related sales.

Eliquis revenue benefited from strong global demand and favorable pricing, while Padcev, the Vyndaqel family and Lorbrena all delivered strong growth. Meanwhile, Paxlovid revenue declined 95% and Comirnaty sales fell 34% as pandemic-related demand continued to normalize.

The company also emphasized continued progress in its obesity and oncology businesses, alongside several expected pivotal clinical readouts over the next 12 months.

Guidance Raised While Cost Savings Expand

Reflecting stronger-than-expected demand for non-COVID products, Pfizer raised the midpoint of its 2026 revenue guidance by $500 million to a range of $60.5 billion to $62.5 billion.

The company reaffirmed its adjusted EPS guidance of $2.80 to $3.00 despite absorbing an expected $0.10 per-share impact from its Innovent Biologics transaction. Pfizer also announced an additional $2.5 billion in anticipated productivity savings to be realized between 2027 and 2029 as part of its ongoing efficiency initiatives.

What to Watch

Despite the modest decline in the stock, investors were encouraged by Pfizer's improving underlying business performance and higher revenue outlook. Going forward, markets will closely monitor continued growth from its non-COVID portfolio, execution of its productivity initiatives, progress in obesity and oncology programs, and upcoming late-stage clinical trial results that could support the company's next phase of growth.

💬 🔗

European Investor 08-04-26

Pfizer (PFE) Stock Rises After FDA Expands PADCEV Plus Keytruda Approval for Muscle-Invasive Bladder Cancer

Pfizer (NYSE: PFE) shares gained about 1.1% after the U.S. Food and Drug Administration approved PADCEV in combination with Keytruda as neoadjuvant and adjuvant treatment for adults with muscle-invasive bladder cancer (MIBC), regardless of cisplatin eligibility.

The expanded approval marks the first platinum-free treatment regimen approved for MIBC across all eligible patient groups, potentially establishing a new standard of care in earlier-stage bladder cancer.

The decision was supported by results from the Phase 3 EV-304 (KEYNOTE-B15) trial, in which PADCEV plus Keytruda demonstrated significant improvements over standard chemotherapy. The combination reduced the risk of tumor recurrence, progression, or death by 47%, lowered the risk of death by 35%, and achieved a pathological complete response rate of 55.8%, compared with 32.5% for standard chemotherapy.

The approval further expands the commercial opportunity for PADCEV, which Pfizer co-develops with Astellas, following its success in advanced bladder cancer. Investors also view the label expansion as strengthening Pfizer’s oncology portfolio by extending the therapy into an earlier-stage, potentially curative treatment setting.

Key factors supporting the stock include:

* The FDA approved PADCEV plus Keytruda for muscle-invasive bladder cancer regardless of cisplatin eligibility.
* The regimen became the first platinum-free treatment approved for this patient population.
* Phase 3 data showed a 47% reduction in the risk of recurrence, progression, or death and a 35% reduction in mortality versus standard chemotherapy.
* The expanded indication broadens PADCEV’s commercial potential and reinforces Pfizer’s long-term oncology growth strategy.

The regulatory approval improved investor sentiment, helping Pfizer shares move higher during the trading session.

💬 🔗

WS News 07-13-26

Pfizer Holds Steady: Solid Q1 Beat, Stock Barely Moves

Tuesday, May 5, 2026

In a sea of earnings-day volatility — Shopify down 7%, Eaton down 6.5% — Pfizer's barely-a-blip 0.27% decline today is almost a compliment. The pharmaceutical giant posted a clean Q1 2026 beat and reaffirmed full-year guidance, delivering exactly what a rebuilding Pfizer needed: no surprises.

The Numbers

Q1 revenues came in at $14.5 billion, up 5% year-over-year (2% operationally), clearing analyst expectations. Reported EPS was $0.47, while adjusted EPS of $0.75 comfortably topped the consensus. Pfizer reaffirmed its full-year 2026 guidance of $59.5–$62.5 billion in revenue and adjusted EPS of $2.80–$3.00 — unchanged from prior guidance.

The headline growth rate of 5% looks modest, but the underlying picture is considerably stronger once COVID-era products are stripped out. Excluding Comirnaty and Paxlovid — both in steep structural decline — revenues grew 7% operationally. More tellingly, revenues from Pfizer's launched and acquired products grew 22% operationally, underscoring that the portfolio transition away from COVID dependency is gaining real traction.

What's Working

The non-COVID portfolio is firing on multiple cylinders. Padcev (bladder cancer) rose 39% operationally on expanding market share. Nurtec (migraine) jumped 41%, driven by strong U.S. demand. Lorbrena (lung cancer) gained 32% on growing first-line patient share. Oncology biosimilars surged 52%, partly on one-time tailwinds but also reflecting genuine supply recovery. Eliquis (blood thinner) grew 8% globally despite some international pricing pressure. Abrysvo (RSV vaccine) also posted 31% growth internationally.

On the cost side, SI&A expenses fell 4% operationally, reflecting tighter, more targeted marketing spend — a sign of the operational discipline CFO David Denton has emphasized. R&D spending rose 12%, directed primarily at oncology and obesity pipelines, two areas CEO Albert Bourla singled out as where Pfizer expects to lead.

What's Dragging

Comirnaty (COVID vaccine) fell 59% operationally and Paxlovid dropped 63%, as COVID infections declined globally and government procurement normalized. Cost of sales as a percentage of revenue climbed to 24.6% from 20.7% a year ago, driven partly by the non-recurrence of a one-time royalty estimate adjustment in 2025 and FX headwinds. Adjusted EPS of $0.75 was also down 18% from $0.92 in Q1 2025, a reminder that the earnings base built during the COVID windfall years is still unwinding.

No share repurchases are planned for 2026, as Pfizer continues to de-lever its balance sheet — a prudent but shareholder-unfriendly near-term posture.

The Takeaway

Pfizer's flat reaction is the right one. This is a company mid-transition: COVID revenues fading, a new growth engine in oncology and obesity building, and pipeline momentum — approximately 20 key pivotal studies on track to start in 2026 — beginning to show up in the numbers. Today's print doesn't resolve Pfizer's long-term story, but it doesn't complicate it either. For now, steady is good enough.

💬 🔗

WS Investor 05-05-26

Pfizer Inc. announced it has reached settlement agreements with generic drugmakers Dexcel Pharma, Hikma Pharmaceuticals, and Cipla regarding patent litigation over its heart disease treatment VYNDAMAX. The agreements extend the drug’s U.S. patent protection to June 2031, delaying expected generic competition.

As a result, Pfizer now anticipates VYNDAMAX revenues to remain relatively stable from 2028 through mid-2031, instead of declining earlier as previously expected. The drug currently holds a strong market position, accounting for around 75% of prescriptions in its category.

The company emphasized that the outcome supports both patient access and the protection of its intellectual property, while ongoing litigation could still impact future developments.

Source: Business Wire

💬 🔗

The Investor 04-28-26

Load More

08-11-26The Investor

07-06-26WS Investor

04-16-26European Investor

01-20-26European Investor

09-30-25WS Investor

NYSE:WMBFollow

Track all markets on TradingView - Prices are not updated in real time

Williams Edges Down 0.1% Premarket Despite Higher Q3 Earnings and Strong EBITDA Growth

Williams (NYSE: WMB) shares slipped about 0.1% in premarket trading despite reporting higher third-quarter 2026 earnings, solid cash flow growth and continued progress across its natural gas infrastructure portfolio.

GAAP net income increased 8% year over year to $699 million, or $0.56 per diluted share. Adjusted net income rose 10% to $663 million, or $0.54 per share, while adjusted EBITDA increased 6% to $2.04 billion.

Cash generation remained strong. Cash flow from operations rose 5% to $1.51 billion, while available funds from operations increased 10% to $1.59 billion. The company reported an AFFO-based dividend coverage ratio of 2.42x.

Williams also continued expanding its growth pipeline. It closed the Momentum Midstream acquisition, announced a 9.4 Bcf storage expansion at Clay Basin, increased Transco capacity through multiple projects and advanced its Socrates power project toward service.

Management said year-to-date adjusted EBITDA increased 9% to $6.2 billion and reiterated confidence in achieving long-term adjusted EBITDA growth of more than 11% annually through 2030.

For 2026, Williams maintained adjusted EBITDA guidance of $8.3 billion-$8.5 billion and said results are tracking toward the upper half of that range. Growth capital spending remains expected at $7.3 billion-$7.9 billion, with a leverage ratio midpoint of about 3.75x.

The slight 0.1% premarket decline suggests investors largely viewed the quarter as in line with expectations. Strong earnings, cash flow and project execution were balanced by unchanged guidance and a still-heavy capital spending program, leaving little incremental catalyst for the shares.

💬 🔗

Global Finance News 11-03-26

# Williams Completes $5.5 Billion Momentum Midstream Acquisition

Williams (NYSE: WMB) has completed its approximately $5.5 billion acquisition of Momentum Midstream, significantly expanding its natural gas infrastructure footprint in the Haynesville basin.

The transaction consists of approximately $3.5 billion in cash and debt consideration and about $2 billion in Williams equity.

## Deal Expands Gulf Coast Natural Gas Network

Momentum adds more than 4,000 miles of pipelines, over 1 million dedicated acres and 6 billion cubic feet per day of gathering capacity to Williams’ network. The assets also include processing and treating facilities and three take-or-pay pipelines with 4.05 Bcf/d of transportation capacity.

The acquisition strengthens Williams’ connection between Haynesville natural gas production and rapidly growing Gulf Coast demand from LNG export facilities, power generation and industrial customers.

Williams said Momentum’s long-term take-or-pay contracts and existing infrastructure also provide a platform for additional expansion projects.

The deal further strengthens Williams’ position as one of the largest U.S. natural gas infrastructure companies, with its existing network already handling roughly one-third of the country’s natural gas.

💬 🔗

The Investor 09-04-26

Williams Companies Stock Rises 2.7% as Morgan Stanley Raises Price Target to $103

Williams Companies (NYSE: WMB) shares are up 2.7% after Morgan Stanley raised its price target on the natural gas infrastructure company, adding another positive Wall Street catalyst for the U.S. midstream energy sector.

Morgan Stanley analyst Robert Kad increased the price target for Williams from $99 to $103 while maintaining an Overweight rating. With WMB trading around $75.42, the new target implies approximately 37% upside.

Morgan Stanley Remains Bullish on Williams

The combination of a higher target and an unchanged Overweight recommendation is a constructive signal. Morgan Stanley raised its valuation expectation by about 4%, while its $103 target remains substantially above Williams' current share price.

Williams holds a particularly important position in the U.S. natural gas infrastructure market. Its pipeline and processing network connects major producing regions with population centers, power generators, industrial customers and LNG-related demand.

A central asset is the Transco pipeline system, one of the largest natural gas transmission networks in the United States. This infrastructure gives Williams significant exposure to structural growth in U.S. natural gas consumption.

AI Data Centers Strengthen the Natural Gas Growth Story

Williams is increasingly positioned to benefit from another major energy theme: rapidly expanding electricity demand from AI data centers.

AI computing facilities require large amounts of reliable, around-the-clock electricity. Natural gas-fired generation is expected to play an important role in meeting incremental power demand in several U.S. markets because it can provide dispatchable generation alongside expanding renewable capacity.

For Williams, this potentially translates into greater demand for pipeline capacity and natural gas transportation rather than simply exposure to higher commodity prices. Its midstream business model therefore provides a different way for investors to participate in increasing U.S. natural gas demand.

Higher natural gas and energy prices can also improve sentiment toward the broader energy sector, although Williams' pipeline-focused business is generally less directly sensitive to commodity prices than upstream producers.

Morgan Stanley's decision to lift its target to $103 while retaining an Overweight rating reinforces the positive longer-term view. With approximately 37% implied upside from the current $75.42 price, the analyst action appears to be an important factor supporting WMB's 2.7% gain.

💬 🔗

European Investor 08-18-26

Williams Companies Ticks Up in Pre-Market on Record Q1 Results

May 5, 2026

Williams (NYSE: WMB) is trading about 0.78% higher in Tuesday's pre-market session after the natural gas infrastructure company posted record first-quarter 2026 results following Monday's close. The muted but positive market reaction reflects a company firing on all cylinders — steady earnings growth, a rising project backlog, and a clear strategic tailwind from surging natural gas demand.

Q1 by the Numbers

GAAP net income came in at $864 million, or $0.70 per diluted share, up 25% compared to the first quarter of 2025. Adjusted net income reached $895 million, or $0.73 per diluted share, up 22% year-over-year. Adjusted EBITDA grew 13% to $2.254 billion, an increase of $265 million from the prior year period.

Cash flow from operations reached $1.603 billion, up 12% year-over-year, while available funds from operations came in at $1.770 billion, a 22% increase. The dividend coverage ratio stood at a comfortable 2.76 times on an AFFO basis — a number that will reassure income-oriented investors that the payout remains well protected.

CEO Chad Zamarin credited the results to the performance of Transco's expansion projects, new Gulf volumes, higher storage revenues, and stronger gathering volumes in the West. Management noted the company is on track to deliver full-year 2026 Adjusted EBITDA in the upper half of its guidance range, a signal of confidence without a formal upward revision.

A Growing Project Portfolio

Beyond the financial results, Williams had a busy quarter on the development front. The company signed a customer agreement for Project Neo, a $2.3 billion behind-the-meter power innovation project with 682 megawatts of installed capacity. It also signed a natural gas infrastructure agreement for Atlas, providing up to 164 MMcf/d of capacity to a Northeast data center — another sign that the company is positioning itself as a key supplier to the rapidly growing data center and AI infrastructure market.

Additional highlights included signing customer agreements on the Silver Spur transmission project, a 275 MMcf/d expansion on Northwest Pipeline, and upsizing Transco's Power Express project to 750 MMcf/d. The company broke ground on Transco's Northeast Supply Enhancement and Southeast Supply Enhancement projects, commissioned the Aristotle pipeline to support data centers in Ohio, and announced approximately 700 MMcf/d of gathering expansions in the Marcellus and Haynesville basins.

On the portfolio management side, Williams closed the sale of its South Mansfield upstream joint venture and Anadarko gathering assets, signaling continued discipline in optimizing its asset base.

The Bigger Picture

Williams is benefiting from a structural shift in energy demand. Natural gas consumption is rising, driven by power generation needs, industrial activity, and the explosive growth of data centers. The company's pipeline and gathering network puts it squarely in the path of that demand, and its expanding roster of power innovation projects suggests management is actively converting that tailwind into long-term contracted revenue.

The modest pre-market gain reflects a market that likes what it sees but is not caught off guard. Williams has been executing consistently, and this quarter was more confirmation than revelation. For investors seeking stable cash flows, strong dividend coverage, and exposure to the natural gas buildout, the quarter offered plenty to feel good about.

💬 🔗

The Investor 05-05-26

Williams (NYSE: WMB) approved a regular dividend of $0.525 per share, $2.10 annualized, on the company’s common stock, payable on June 29, 2026, to holders of record at the close of business on June 12, 2026.

💬 🔗

The Investor 04-28-26

Williams Companies Inc. began construction on its Northeast Supply Enhancement (NESE) pipeline project, aimed at boosting natural gas capacity in the U.S. Northeast.

The project will add capacity to supply energy for up to 2.3 million homes and is expected to be operational by late 2027.
Business Wire

💬 🔗

WS Investor 04-14-26

Williams reported strong unaudited financial results for the three and twelve months ended December 31, 2025, driven by its natural gas–focused strategy and continued project execution.

For full year 2025, Williams posted GAAP net income of $2.62 billion, or $2.14 per diluted share, representing an 18% increase year over year. Adjusted net income reached $2.57 billion, or $2.10 per diluted share, up 10% and 9%, respectively. Adjusted EBITDA rose 9% year over year to a record $7.75 billion, while cash flow from operations increased 19% to $5.90 billion. Available funds from operations totaled $5.86 billion, up 9% compared with 2024.

The company ended the year with a dividend coverage ratio of 2.40x on an AFFO basis and announced a 5% increase in its dividend to $2.10 annualized for 2026, marking its 52nd consecutive year of dividend payments. For 2026, Williams issued adjusted EBITDA guidance of $8.05 billion to $8.35 billion, representing approximately 6% growth at the midpoint versus 2025.

Operationally, Williams completed 12 projects in 2025 across pipeline transmission, gathering, and deepwater assets, and announced 10 additional projects during the year, including pipeline, storage, and power innovation initiatives. The company also executed the Haynesville E&P sale and strategic partnership with Woodside Energy, closed the acquisitions of Rimrock and Saber Midstream, and expanded its power innovation portfolio with a new project, Socrates the Younger.

Chief Executive Officer Chad Zamarin highlighted that Williams’ consistent execution has resulted in a five-year adjusted EBITDA CAGR of 9% and a five-year EPS CAGR of 14%, positioning the company for continued growth as new pipeline transmission, offshore, and power innovation projects come online in 2026 and beyond.

Source: Business Wire

💬 🔗

WS Investor 02-10-26

Williams announced that its board of directors has approved a regular quarterly dividend of $0.525 per share, or $2.10 on an annualized basis.

The dividend represents a 5% increase from the company’s fourth-quarter 2025 dividend of $0.50 per share. It will be payable on March 30, 2026, to shareholders of record as of March 13, 2026. Williams noted that a portion of the distribution may be treated as a return of capital for tax purposes.

The company highlighted that it has paid a common stock dividend every quarter since 1974.

Source: Business Wire

💬 🔗

WS Investor 01-27-26

Williams announced that it has priced a $2.75 billion public offering of senior notes, strengthening its balance sheet and extending its debt maturity profile. The offering consists of $500 million of 5.650% senior notes due 2033, $1.25 billion of 5.150% senior notes due 2036, and $1.0 billion of 5.950% senior notes due 2056. The expected settlement date is January 8, 2026, subject to customary closing conditions.

The newly issued 2033 notes represent an additional tranche of Williams’ existing 5.650% senior notes originally issued in March 2023, bringing the total outstanding amount of those notes to $1.25 billion. The longer-dated tranches were priced close to par, reflecting solid investor demand across the maturity spectrum.

Williams said it plans to use the net proceeds primarily to repay near-term debt maturities, including its $1.1 billion of 5.400% senior notes due in 2026, as well as for general corporate purposes.

💬 🔗

WS Investor 01-08-26

Northwest Pipeline LLC, a subsidiary of The Williams Companies, entered into a new $250 million term loan facility on December 1, 2025, according to a regulatory filing. The credit agreement, arranged with PNC Bank as administrative agent, funds the refinancing of Northwest Pipeline’s 7.125% senior notes that matured the same day and also provides capital for working capital, acquisitions, and general corporate purposes.

The three-year term loan bears interest at either an Alternate Base Rate or Adjusted Term SOFR, plus an applicable margin tied to the company’s senior unsecured debt ratings. Northwest Pipeline must maintain a debt-to-capitalization ratio of no more than 65%, tested quarterly.

The facility includes customary covenants and events of default, giving lenders the right to accelerate repayment if triggered.

💬 🔗

European Investor 12-02-25

Load More

NASDAQ:TWFollow

Track all markets on TradingView - Prices are not updated in real time

Tradeweb Launches Muni Sweep to Speed Municipal Bond Trading

Tradeweb Markets (NASDAQ: TW) launched Muni Sweep, a new session-based trading protocol designed to help municipal bond market participants evaluate and trade inventory more efficiently.

The workflow concentrates municipal bond inventory into a short, defined trading window. Participants can review opportunities, compare pricing against Tradeweb composite levels and accept relevant interest before the session closes. The company said the process is designed to reduce risk tie-up from hours under traditional bid-wanted workflows to minutes.

The launch comes as electronic trading continues to expand across the municipal bond market. According to data cited by Tradeweb, the market recorded 17.6 million trades in 2025, up 22% year over year, while electronic trading share increased from 16% in 2022 to nearly 21% in the second quarter of 2026.

Tradeweb has also been seeing stronger municipal trading activity on its own platform. Municipal bond average daily volume reached a record level in the third quarter of 2026, with September ADV rising 40% year over year to $729 million.

Muni Sweep allows users to upload inventory with CUSIP, size and an optional yield or price, while Tradeweb supplies composite pricing for comparison. The platform also includes filtering, sorting and Excel import and export functionality to support the review of large inventories.

The protocol extends a session-based trading model Tradeweb already uses across other markets. More than 25 similar sessions currently take place each week across 10 products on the company’s global wholesale platform.

The launch expands Tradeweb’s municipal bond workflow capabilities as dealers increasingly seek faster inventory turnover, greater price transparency and more efficient electronic execution.

💬 🔗

The Investor 11-03-26

Tradeweb Markets Posts Strong Q1 2026 with 21% Revenue Growth

Tradeweb Markets reported quarterly revenues of $617.8 million for the first quarter of 2026, up 21.2% year over year. Average daily trading volume reached $3.3 trillion, a 31.4% increase from the prior year period, with record volumes set across numerous asset classes including US and European government bonds, credit, ETFs, and repurchase agreements. Net income grew 38.5% to $233.2 million, while adjusted EBITDA came in at $339.7 million, reflecting a 55% margin. The company also raised its quarterly cash dividend by 16.7% to $0.14 per share.

Source: Tradeweb Markets Inc. Busines Wire

💬 🔗

Global Finance News 04-29-26

Tradeweb Markets announced an expansion of its iNAV (indicative net asset value) service after Xtrackers by DWS adopted the platform for its Europe-listed ETFs. The move increases Tradeweb’s iNAV coverage to more than 50% of total assets under management in Europe-listed ETFs.

The iNAV service provides real-time, intraday ETF valuations based on underlying assets, updating every few seconds to reflect market conditions. The expansion is expected to enhance pricing transparency, improve trading efficiency, and support better execution decisions for investors.

Tradeweb said the adoption highlights growing demand for independent, real-time valuation data as ETF markets become increasingly automated and data-driven, particularly in volatile or less liquid environments.
Business Wire

💬 🔗

European Investor 04-21-26

Tradeweb Markets Inc. reported record trading activity in March 2026, driven by heightened market volatility and strong client engagement across asset classes.

Total trading volume reached $87 trillion for the month, while average daily volume (ADV) hit a record $3.8 trillion, up 41.8% year-on-year. For the first quarter, total volume climbed to $214.3 trillion, with ADV rising 31.4% to $3.3 trillion.

The company said growth was broad-based, with record activity in government bonds, credit products, derivatives, and ETFs, supported by increased adoption of automated trading tools.

Tradeweb noted that rising market volatility is accelerating the shift toward electronic trading, with clients increasingly relying on automation and digital platforms to execute trades efficiently.
Business Wire

💬 🔗

WS Investor 04-07-26

Tradeweb Markets Inc. (Nasdaq: TW) will release financial results for the first quarter of 2026 on Wednesday, April 29, 2026

💬 🔗

European Investor 03-28-26

Tradeweb Markets announced the expansion of its dealer algorithmic execution offering for U.S. Treasuries by adding strategies from Citi and RBC Capital Markets.

The move builds on the platform’s initial U.S. rollout of algorithmic trading tools and aims to provide institutional investors with deeper liquidity, more diversified execution strategies, and enhanced trading efficiency. The expanded offering allows clients to execute trades over defined time horizons while accessing advanced, bank-developed quantitative algorithms.

Tradeweb stated that the enhancement supports its broader strategy of integrating algorithmic execution with its data and analytics capabilities, moving toward a unified multi-dealer, multi-asset trading platform. The company also highlighted strong activity in its U.S. government bond marketplace, with average daily trading volumes reaching $237.2 billion in 2025, up 11.6% year-over-year.
Business Wire

💬 🔗

Global Finance News 03-19-26

Tradeweb Markets (Nasdaq: TW) and Kalshi announced a strategic partnership to expand institutional access to prediction markets, with Tradeweb also making a minority investment in Kalshi.

The collaboration aims to integrate Kalshi’s real-time event probabilities and prediction market data into Tradeweb’s institutional trading platform, initially across rates and credit marketplaces via UI, APIs, and data tools. The companies plan to co-develop institutional-grade analytics combining Kalshi’s event data with Tradeweb’s pricing, liquidity, and macro datasets to support forecasting, risk management, and trading strategies.

They will also explore creating the first institutional-focused portal for standardized event contracts, including macroeconomic releases, Federal Reserve policy decisions, and political elections, with Tradeweb serving as the institutional front end.

Tradeweb facilitates over $2.6 trillion in average daily notional trading volume and serves more than 3,000 clients globally, while Kalshi is the largest regulated prediction market platform.

Source: Business Wire.

💬 🔗

WS Investor 02-19-26

Tradeweb Markets Inc. announced a strategic investment and commercial collaboration with MAXEX to expand institutional access to the U.S. residential mortgage market. Financial terms were not disclosed.

The partnership aims to create a more centralized, transparent and scalable marketplace for residential whole loans by connecting Tradeweb’s global network of more than 3,000 clients with MAXEX’s network of around 400 mortgage lenders and over three dozen institutional investors. The integration will combine MAXEX’s centralized exchange and clearinghouse with Tradeweb’s electronic trading, data and workflow capabilities to enhance efficiency and liquidity in private residential credit.

The collaboration extends Tradeweb’s mortgage offering beyond agency MBS into the growing private residential credit segment. As part of the investment, MAXEX appointed Troy Dixon of Tradeweb and Marc Simpson of JPMorgan to its board.

Source: Business Wire.

💬 🔗

European Investor 02-12-26

Tradeweb Markets (Nasdaq: TW) announced it has completed the industry’s first fully electronic swaption termination. The inaugural transaction was executed between Citadel and Wells Fargo on Tradeweb’s Swap Execution Facility (TW SEF), with post-trade processing handled through OSTTRA’s MarkitWire platform.

The milestone expands Tradeweb’s swaption capabilities, addressing a long-standing challenge in bilateral derivatives markets where swaptions cannot be easily compressed and must be terminated or novated before expiry. The new functionality allows clients to input a MarkitWire ID directly into the Tradeweb platform, automatically retrieving trade details, matching offsetting positions and reducing booking errors. Termination notifications are then sent electronically to MarkitWire to accelerate confirmation.

Tradeweb said the enhancement helps clients streamline workflows, reduce gross notional exposure and improve operational efficiency. The platform currently supports 18 swaption dealers and has been active in USD, EUR and GBP interest rate swaps markets since 2005.

Source: Business Wire

💬 🔗

WS Investor 02-11-26

Tradeweb Markets Inc. reported strong fourth-quarter and full-year 2025 results, driven by higher trading activity across multiple asset classes. Fourth-quarter revenues rose 12.5% year over year to $521.2 million, supported by a 23.3% increase in average daily volume to $2.8 trillion, with record quarterly volumes in European government bonds, longer-dated swaps and swaptions, U.S. ETFs, and global repurchase agreements. International revenues climbed 16.8% to $220.2 million.

Net income for the quarter surged 129.5% to $367.1 million, while adjusted net income increased 14.2% to $207.0 million. Adjusted EBITDA reached $277.3 million, representing a 53.2% margin, compared with 52.8% a year earlier. Diluted EPS was $1.51, with adjusted diluted EPS of $0.87. Tradeweb also announced a 16.7% increase in its quarterly cash dividend to $0.14 per share and authorized a new $500 million share repurchase program.

Source: Tradeweb Markets Inc. press release

💬 🔗

WS Investor 02-06-26

Load More

NYSE:KDPFollow

Keurig Dr Pepper Falls 5.8% as Reaffirmed Guidance and Coffee Pressures Offset Strong Q3 Growth

Keurig Dr Pepper (NASDAQ: KDP) shares fell about 5.8% despite reporting strong third-quarter 2026 sales and earnings growth, as investors appeared to focus on softer legacy coffee economics and the absence of a guidance increase.

Third-quarter net sales rose 70.6% to $7.34 billion, largely reflecting the addition of JDE Peet’s. Excluding that acquisition, legacy KDP sales still increased 8.6%, driven by 6.5% volume/mix growth and 2.1% pricing.

Adjusted operating income increased 52.5% to $1.7 billion, while adjusted EPS rose 22.2% to $0.66. Free cash flow was also strong at $1.01 billion.

The U.S. Refreshment Beverages business remained healthy, with sales up 10.9% to $3.0 billion. U.S. Coffee was more mixed: revenue increased 2.7% to $1.0 billion, but favorable 6.9% volume/mix growth was partly offset by a 4.2% decline in net pricing. Adjusted operating income rose 11.4%, helped in part by tariff refunds.

KDP reaffirmed its 2026 outlook for $25.9 billion-$26.4 billion in sales and low-double-digit adjusted EPS growth. The company now expects the JDE Peet’s acquisition to contribute 7-8 percentage points to EPS growth, while legacy KDP EPS growth is expected at 3%-5%, reflecting revised expectations for U.S. Coffee.

The 5.8% decline appears to reflect concern that underlying legacy growth is less robust than the headline consolidated numbers suggest. Investors may also be focusing on weaker pricing in U.S. Coffee, higher cost pressures, acquisition-related complexity and the fact that full-year guidance was reaffirmed rather than raised despite strong reported Q3 growth.

💬 🔗

The Investor 11-03-26

Keurig Dr Pepper (NASDAQ: KDP) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.23 per share, payable in U.S. dollars, on the Company's common stock. The regular quarterly dividend will be paid on October 9, 2026 to shareholders of record on September 28, 2026.

💬 🔗

The Investor 09-17-26

Keurig Dr Pepper to Receive $925 Million From Chobani Deals, Supporting Debt Reduction

Keurig Dr Pepper (NASDAQ: KDP) announced Tuesday a series of transactions with Chobani that will generate approximately $925 million in pre-tax proceeds while expanding the companies’ long-term commercial partnership.

KDP will sell its entire minority equity stake in Chobani back to the company for $800 million. Separately, Chobani will acquire KDP’s manufacturing and warehouse facility in Allentown, Pennsylvania, for approximately $125 million, including the facility lease, equipment and operations.

Keurig Dr Pepper plans to use the net proceeds primarily to reduce debt, supporting its deleveraging strategy as it prepares to operate its future Beverage Co. and Global Coffee Co. businesses. The transactions are expected to close during the third quarter of 2026, subject to customary conditions.

Despite selling its Chobani investment, KDP is strengthening the companies’ commercial relationship. KDP will continue distributing La Colombe ready-to-drink lattes and other Chobani-owned beverages through its direct-store-delivery network, with the agreement expanded to cover future RTD products. The companies will also maintain their licensing, manufacturing and distribution arrangement for La Colombe-branded K-Cup pods in the U.S. and Canada.

Chobani will also continue manufacturing certain KDP products at the Allentown facility for a transitional period.

For KDP, the transactions provide a sizable cash inflow without ending its commercial exposure to Chobani’s beverage brands. Using the proceeds to reduce leverage could strengthen the balance sheet ahead of the planned business separation, while the expanded distribution agreement preserves opportunities to benefit from growth in La Colombe and future Chobani beverage launches.

💬 🔗

WS Investor 09-01-26

KDP Stock Gains After Morgan Stanley Starts Coverage With Overweight Rating

Keurig Dr Pepper (NASDAQ: KDP) shares rose about 2.4% after Morgan Stanley initiated coverage of the beverage company with an Overweight rating.

Analyst Dara Mohsenian set a $38 price target. Based on the $31.82 current share price, the target implies roughly 19% upside.

The bullish initiation suggests Morgan Stanley sees an attractive risk-reward profile for KDP. As a major player in the North American beverage sector, Keurig Dr Pepper combines its established coffee platform with a broad portfolio of soft drinks and other beverages, providing diversification across several consumer categories.

The positive analyst coverage appears to be supporting KDP shares, with the stock gaining about 2.4% following the report.

💬 🔗

WS Investor 08-20-26

# Keurig Dr Pepper (KDP) Rises 4.6% After HSBC Upgrades Stock to Buy

Keurig Dr Pepper (NASDAQ: KDP) shares are up 4.6% after HSBC upgraded the beverage company from Hold to Buy, providing a positive catalyst for the stock.

HSBC analyst Sorabh Daga maintained a $40 price target. Based on the $30.93 share price shown in the report, the target implies roughly 29% upside potential.

## Why Is KDP Stock Up?

The upgrade likely reflects a more favorable view of Keurig Dr Pepper’s risk-reward profile and outlook within the consumer staples and beverage sector. KDP has a diversified portfolio spanning soft drinks, coffee and other beverages, giving the company exposure to both at-home consumption through Keurig and major beverage brands such as Dr Pepper.

The unchanged $40 target alongside the move from Hold to Buy suggests HSBC sees the stock's current valuation as increasingly attractive rather than necessarily making a major change to its underlying earnings assumptions.

The 4.6% gain indicates investors are responding positively to the more bullish recommendation, particularly as the $40 target represents meaningful upside from current levels.

💬 🔗

European Investor 08-13-26

Keurig Dr Pepper reported first-quarter 2026 net sales of $4.0 billion, up 9.4% year-over-year, driven by strong growth in its U.S. refreshment beverages segment. Adjusted earnings per share came in at $0.39, down 7.1%, reflecting inflationary pressures and higher marketing costs.

The company highlighted solid momentum in cold beverages, while coffee sales declined due to weaker volumes. Profitability was impacted by acquisition-related expenses and cost pressures, although productivity gains and pricing actions provided some offset.

Keurig Dr Pepper also confirmed the completion of its acquisition of JDE Peet’s and reaffirmed its full-year 2026 outlook, expecting continued sales growth and double-digit adjusted EPS expansion.

Source: PR Newswire

💬 🔗

The Investor 04-24-26

Keurig Dr Pepper and Nestlé USA have renewed and expanded their strategic partnership to continue manufacturing and distributing Starbucks K-Cup pods across the U.S. and Canada.

The extended agreement builds on their collaboration since 2020 and introduces new initiatives to expand distribution and drive innovation within the Keurig single-serve brewing system.

Under the arrangement, Nestlé will continue overseeing the distribution of Starbucks at-home coffee products in retail channels, while Keurig Dr Pepper leverages its platform to deliver a wide range of Starbucks coffee offerings to consumers.

Both companies said the partnership strengthens their ability to grow the at-home coffee segment and enhance product innovation, reinforcing the Starbucks brand within the Keurig ecosystem.
PRNewswire

💬 🔗

WS Investor 04-21-26

Keurig Dr Pepper announced it has acquired a 96.22% stake in JDE Peet's, creating a major global coffee platform as part of its strategic transformation.

The deal combines KDP’s Keurig business with JDE Peet’s global coffee portfolio, with plans to eventually separate into two independent publicly traded companies: a North American beverage company and a global coffee-focused entity.

KDP also named Rafael Oliveira as CEO of the future Global Coffee Co., while current CEO Tim Cofer is expected to lead the standalone beverage business after the planned separation.

The transaction positions the combined coffee operations to scale globally across multiple brands, channels, and markets, with integration efforts focused on synergies, operational efficiency, and long-term growth.

💬 🔗

Global Finance News 04-03-26

Keurig Dr Pepper announced that its takeover offer for JDE Peet's has been declared unconditional after securing 96.22% shareholder acceptance.

A total of approximately 466.7 million shares were tendered during the offer period, representing a transaction value of about €14.9 billion. With all conditions satisfied, settlement is scheduled for April 1, 2026.

Following completion, Keurig Dr Pepper will proceed with delisting JDE Peet’s from Euronext Amsterdam and may initiate buyout procedures for remaining shareholders. A post-closing acceptance period will run from March 30 to April 13, 2026, allowing additional shareholders to tender their shares.

The deal marks a major consolidation in the global beverage and coffee sector, positioning Keurig Dr Pepper to expand its footprint across international coffee markets.
PRNewswire

💬 🔗

European Investor 03-28-26

Keurig Dr Pepper Inc. (NASDAQ: KDP) will release its financial results for the first quarter ended March 31, 2026 before the market opens on Thursday, April 23, 2026.

💬 🔗

Global Finance News 03-27-26

Load More

02-24-26WS News

10-28-25WS Investor

10-27-25The Investor

09-30-25WS Investor

07-24-25European Investor

TurkeyFollow

Track all markets on TradingView - Prices are not updated in real time

Turkey Inflation Rises More Than Expected in October

Turkey’s consumer price inflation accelerated in October, coming in slightly above market expectations on both a monthly and annual basis.

Consumer prices increased 2.58% month over month, above the 2.40% forecast and accelerating from September’s 1.84% increase.

Annual inflation rose to 29.77% from 29.73%, also exceeding expectations of 29.56%. The result indicates that the disinflation process stalled slightly during the month rather than continuing the expected gradual decline.

The stronger-than-expected inflation readings could reinforce a cautious stance from the Central Bank of the Republic of Turkey. Persistent monthly price pressures may reduce the scope for faster monetary easing, particularly if subsequent inflation data continue to exceed forecasts.

💬 🔗

Global Finance News 11-03-26

Turkey Inflation Slows Sharply in September, Coming Below Expectations

Turkey’s consumer price index rose 1.84% month over month in September, below the 2.30% increase expected by economists and matching the previous month’s pace.

On an annual basis, inflation slowed to 29.73% from 31.51%, also coming in below the 30.30% market consensus.

The data indicate that disinflation continued during September, with the annual rate falling below 30% and the monthly increase remaining relatively contained.

💬 🔗

European Investor 10-05-26

Turkey Consumer Confidence Rises to 91.9 in September

Turkey’s Consumer Confidence Index increased to 91.9 in September from 90.8 previously, signaling a modest improvement in household sentiment.

The rise suggests consumers became somewhat less pessimistic about the economic outlook, personal finances and spending conditions compared with the previous month.

However, the index remains below the 100 threshold, which indicates that overall consumer sentiment is still in pessimistic territory.

💬 🔗

WS News 09-22-26

Turkey Capacity Utilization Rises in September as Manufacturing Confidence Eases

Turkey’s manufacturing capacity utilization rate increased to 74.2% in September from 73.5% previously, pointing to somewhat stronger use of existing production capacity.

At the same time, the Manufacturing Confidence Index slipped to 102.0 from 102.8. Because the index remained above 100, sentiment among manufacturers was still in positive territory, though confidence weakened slightly from the prior month.

💬 🔗

WS News 09-21-26

Turkey Inflation Eases Slightly Below Forecasts in August

Turkey’s consumer inflation came in slightly below market expectations in August, although monthly price pressures remained elevated.

The Consumer Price Index rose 1.84% month over month, below the 1.93% consensus estimate but slightly faster than the 1.78% increase recorded in July. The figures show that prices continued to rise at a substantial monthly pace despite the downside surprise relative to forecasts.

Annual inflation stood at 31.51% in August, also slightly below the market consensus of 31.62%. The reading indicates that Turkey’s broader disinflation process is continuing, even as persistent monthly price increases underline the challenges facing policymakers in bringing inflation sustainably lower.

For the Central Bank of the Republic of Türkiye, the softer-than-expected headline figures could provide some support for further monetary easing. However, the acceleration in monthly inflation from July suggests policymakers may remain cautious about the pace of rate cuts, particularly as they monitor domestic demand, inflation expectations and the Turkish lira.

💬 🔗

WS News 09-03-26

Turkish Economy Slows to 2.3% Growth in Q2, Missing Forecast

Turkiye’s economy expanded 2.3% year-over-year in the second quarter of 2026, falling short of market expectations for 2.9% growth.

The result also marked a slowdown from the 2.6% annual growth recorded in the previous quarter, indicating that economic momentum weakened during Q2.

💬 🔗

Global Finance News 08-31-26

Turkiye's economy expanded 2.5% year-over-year in the first quarter, falling short of expectations for 2.7% growth and slowing from 3.4% in the previous quarter.

💬 🔗

European Investor 06-01-26

Turkey’s April inflation data came in above expectations, signaling renewed upward pressure on prices.

CPI rose 4.18% month-over-month, significantly higher than the 3.28% forecast and accelerating from 1.94% in March. On an annual basis, inflation reached 32.37%, also exceeding expectations of 31.25% and up from 30.87%.

The sharp monthly increase is the key signal here. It suggests a loss of short-term disinflation momentum

💬 🔗

European Investor 05-04-26

Türkiye’s gross foreign exchange reserves declined to $61.82 billion from $64.07 billion, indicating a reduction in overall reserve buffers.

In contrast, net FX reserves improved to 58.38% from 55.59%, suggesting a relative strengthening in usable reserves despite the drop in total holdings.

💬 🔗

European Investor 04-24-26

Turkey’s overnight borrowing rate remained unchanged at 35.50% in April, in line with market expectations and the previous reading.

💬 🔗

The Investor 04-22-26

Load More

10-15-25European Investor

03-26-25Global Finance News

03-24-25Global Finance News